Bacteroides eggerthii 10128 is an anaerobe bacterium that was isolated from human faeces.
anaerobe genome sequence 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacteroidota |
| Class Bacteroidia |
| Order Bacteroidales |
| Family Bacteroidaceae |
| Genus Bacteroides |
| Species Bacteroides eggerthii |
| Full scientific name Bacteroides eggerthii Holdeman and Moore 1974 (Approved Lists 1980) |
| BacDive ID | Other strains from Bacteroides eggerthii (1) | Type strain |
|---|---|---|
| 158880 | B. eggerthii WCA3-601-WT-5E, DSM 107245 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 9017 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 9017 | FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) | Medium recipe at MediaDive | Name: FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) Composition: Fastidious Anaerobe Basal Broth 35.4 g/l Distilled water | ||
| 9017 | PYG MEDIUM (MODIFIED) (DSMZ Medium 104) | Medium recipe at MediaDive | Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water | ||
| 41096 | MEDIUM 20 - for Anaerobic bacteria | Agar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml) | |||
| 118999 | CIP Medium 20 | Medium recipe at CIP |
| 67770 | Observationquinones: MK-10, MK-11 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68381 | 40585 ChEBI | alpha-cyclodextrin | + | builds acid from | from API rID32STR |
| 68381 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32STR |
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68381 | 18333 ChEBI | D-arabitol | - | builds acid from | from API rID32STR |
| 68381 | 16899 ChEBI | D-mannitol | - | builds acid from | from API rID32STR |
| 68380 | 16024 ChEBI | D-mannose | + | fermentation | from API rID32A |
| 68381 | 16988 ChEBI | D-ribose | - | builds acid from | from API rID32STR |
| 68381 | 16443 ChEBI | D-tagatose | - | builds acid from | from API rID32STR |
| 68381 | 28087 ChEBI | glycogen | + | builds acid from | from API rID32STR |
| 68381 | 606565 ChEBI | hippurate | - | hydrolysis | from API rID32STR |
| 68381 | 30849 ChEBI | L-arabinose | + | builds acid from | from API rID32STR |
| 68380 | 29985 ChEBI | L-glutamate | + | degradation | from API rID32A |
| 68381 | 17716 ChEBI | lactose | + | builds acid from | from API rID32STR |
| 68381 | 17306 ChEBI | maltose | + | builds acid from | from API rID32STR |
| 68381 | 6731 ChEBI | melezitose | - | builds acid from | from API rID32STR |
| 68381 | 28053 ChEBI | melibiose | - | builds acid from | from API rID32STR |
| 68381 | 320055 ChEBI | methyl beta-D-glucopyranoside | - | builds acid from | from API rID32STR |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 68381 | 27941 ChEBI | pullulan | + | builds acid from | from API rID32STR |
| 68381 | 16634 ChEBI | raffinose | - | builds acid from | from API rID32STR |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 68381 | 30911 ChEBI | sorbitol | - | builds acid from | from API rID32STR |
| 68381 | 17992 ChEBI | sucrose | - | builds acid from | from API rID32STR |
| 68381 | 27082 ChEBI | trehalose | - | builds acid from | from API rID32STR |
| 68380 | 27897 ChEBI | tryptophan | + | energy source | from API rID32A |
| 68381 | 16199 ChEBI | urea | - | hydrolysis | from API rID32STR |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68381 | 15688 ChEBI | acetoin | from API rID32STR | |
| 68380 | 35581 ChEBI | indole | from API rID32A |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | Indole test | |
|---|---|---|---|---|---|
| 68381 | 15688 ChEBI | acetoin | - | from API rID32STR | |
| 68380 | 35581 ChEBI | indole | + | from API rID32A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68380 | alanine arylamidase | + | 3.4.11.2 | from API rID32A |
| 68381 | Alanyl-Phenylalanyl-Proline arylamidase | + | from API rID32STR | |
| 68380 | alkaline phosphatase | + | 3.1.3.1 | from API rID32A |
| 68381 | alkaline phosphatase | + | 3.1.3.1 | from API rID32STR |
| 68380 | alpha-arabinosidase | + | 3.2.1.55 | from API rID32A |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68381 | alpha-galactosidase | + | 3.2.1.22 | from API rID32STR |
| 68380 | alpha-galactosidase | - | 3.2.1.22 | from API rID32A |
| 68380 | alpha-glucosidase | + | 3.2.1.20 | from API rID32A |
| 68381 | arginine dihydrolase | - | 3.5.3.6 | from API rID32STR |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68380 | beta-galactosidase | + | 3.2.1.23 | from API rID32A |
| 68381 | beta-galactosidase | + | 3.2.1.23 | from API rID32STR |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68381 | beta-glucosidase | + | 3.2.1.21 | from API rID32STR |
| 68381 | beta-glucuronidase | - | 3.2.1.31 | from API rID32STR |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 68381 | beta-mannosidase | - | 3.2.1.25 | from API rID32STR |
| 68380 | glutamate decarboxylase | + | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | + | from API rID32A | |
| 68380 | glycin arylamidase | - | from API rID32A | |
| 68381 | glycyl tryptophan arylamidase | + | from API rID32STR | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | L-arginine arylamidase | - | from API rID32A | |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | + | 3.4.11.1 | from API rID32A |
| 68380 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 | from API rID32A |
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 68381 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32STR |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68380 | tryptophan deaminase | + | 4.1.99.1 | from API rID32A |
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 68381 | urease | - | 3.5.1.5 | from API rID32STR |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9017 | - | - | - | + | - | + | - | + | - | + | + | - | + | - | - | + | + | - | - | + | - | - | - | - | + | - | - | + | - | |
| 9017 | - | - | - | + | - | + | + | + | - | + | + | - | + | - | - | + | + | - | - | + | - | - | - | - | + | - | - | + | - |
| @ref | ADH (Arg) | beta GLU | beta GAR | beta GUR | alpha GAL | PAL | RIB | MAN | SOR | LAC | TRE | RAF | SAC | LARA | DARL | Acid from alpha-cyclodextrinCDEX | Acetoin production (Voges Proskauer test)VP | Alanyl-Phenylalanyl-Proline arylamidaseAPPA | beta GAL | Pyrrolidonyl arylamidasePyrA | N-Acetyl-glucosaminidasebeta NAG | Glycyl-tryptophan arylamidaseGTA | HIP | GLYG | PUL | MAL | MEL | MLZ | Acidification of methyl beta-D-glucopyranosideMbeta DG | TAG | beta MAN | URE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9017 | - | + | + | - | + | + | - | - | - | + | - | - | - | + | - | + | - | + | + | - | +/- | + | - | + | + | + | - | - | - | - | - | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
Global distribution of 16S sequence AB510700 (>99% sequence identity) for Bacteroides eggerthii subclade from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2514656v1 assembly for Bacteroides eggerthii DSM 20697 | complete | 28111 | 97.3 | ||||
| 66792 | 48853_E02 assembly for Bacteroides eggerthii NCTC11155 | contig | 28111 | 76.87 | ||||
| 67770 | ASM15581v1 assembly for Bacteroides eggerthii DSM 20697 | scaffold | 483216 | 64.49 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Bacteroides eggerthii 16S-23S rDNA intergenic spacer region | AF176690 | 378 | 483216 | ||
| 9017 | Bacteroides eggerthii gene for 16S rRNA, partial sequence | AB050107 | 1425 | 483216 | ||
| 67770 | Bacteroides eggerthii gene for 16S ribosomal RNA, partial sequence, strain: JCM 12986 | AB510700 | 1488 | 28111 | ||
| 124043 | Bacteroides eggerthii strain JCM12986 16S ribosomal RNA gene, partial sequence. | EU136695 | 1991 | 28111 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | oxygen_tolerance | BacteriaNetⓘ | obligate anaerobe | 99.87 | no |
| 125439 | gram_stain | BacteriaNetⓘ | negative | 97.50 | no |
| 125439 | motility | BacteriaNetⓘ | no | 85.36 | no |
| 125439 | spore_formation | BacteriaNetⓘ | no | 99.98 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | no | 94.87 | no |
| 125438 | anaerobic | anaerobicⓘ | yes | 89.74 | no |
| 125438 | aerobic | aerobicⓘ | no | 92.64 | yes |
| 125438 | spore-forming | spore-formingⓘ | no | 92.48 | no |
| 125438 | thermophilic | thermophileⓘ | no | 95.77 | yes |
| 125438 | flagellated | motile2+ⓘ | no | 89.00 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Pathogenicity | Hepatoprotective Potential of Bacteroides eggerthii on Fatty Liver Disease: A Mouse Model Study. | Chen LW, Wu IW, Cheng TC, Chang LC, Hsu CK, Yeung L, Chang LC, Su SC. | In Vivo | 10.21873/invivo.14122 | 2025 | |
| Enzymology | Action and cooperation in alginate degradation by three enzymes from the human gut bacterium Bacteroides eggerthii DSM 20697. | Ronne ME, Dybdahl Andersen C, Teze D, Petersen AB, Fredslund F, Stender EGP, Chaberski EK, Holck J, Aachmann FL, Welner DH, Svensson B. | J Biol Chem | 10.1016/j.jbc.2024.107596 | 2024 | |
| A Porphyromonas gingivalis hypothetical protein controlled by the type I-C CRISPR-Cas system is a novel adhesin important in virulence. | Irfan M, Solbiati J, Duran-Pinedo A, Rocha FG, Gibson FC, Frias-Lopez J. | mSystems | 10.1128/msystems.01231-23 | 2024 | ||
| When simplicity triumphs: niche specialization of gut bacteria exists even for simple fiber structures. | Xu H, Pudlo NA, Cantu-Jungles TM, Tuncil YE, Nie X, Kaur A, Reuhs BL, Martens EC, Hamaker BR. | ISME Commun | 10.1093/ismeco/ycae037 | 2024 | ||
| Non-targeted metabolomics and microbial analyses of the impact of oat antimicrobial peptides on rats with dextran sulfate sodium-induced enteritis. | Wang H, Xie L, Liu S, Dai A, Chi X, Zhang D. | Front Nutr | 10.3389/fnut.2022.1095483 | 2022 | ||
| Mapping the T cell repertoire to a complex gut bacterial community. | Nagashima K, Zhao A, Atabakhsh K, Bae M, Blum JE, Weakley A, Jain S, Meng X, Cheng AG, Wang M, Higginbottom S, Dimas A, Murugkar P, Sattely ES, Moon JJ, Balskus EP, Fischbach MA. | Nature | 10.1038/s41586-023-06431-8 | 2023 | ||
| Comparison of the gut microbiota in older people with and without sarcopenia: a systematic review and meta-analysis. | Ren Y, He X, Wang L, Chen N. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1480293 | 2025 | ||
| Determinants of raffinose family oligosaccharide use in Bacteroides species. | Basu A, Adams AND, Degnan PH, Vanderpool CK. | J Bacteriol | 10.1128/jb.00235-24 | 2024 | ||
| Heterologous expression and antimicrobial potential of class II bacteriocins. | Elisa Heesemann Rosenkilde C, Olsen Lutzhoft D, Vazquez-Uribe R, Otto Alexander Sommer M. | Gut Microbes | 10.1080/19490976.2024.2369338 | 2024 | ||
| Investigation on L-rhamnose metabolism of Loigolactobacillus coryniformis subsp. coryniformis DSM 20001 and its propionate-containing fermentates. | Elvan Gezer M, Gravlund Fonss K, Bambace MF, Marietou A, Sandberg Overby S, Sundekilde U, Schwab C. | Appl Environ Microbiol | 10.1128/aem.01613-24 | 2025 | ||
| Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. | Masetti R, Biagi E, Zama D, Muratore E, D'Amico F, Leardini D, Turroni S, Prete A, Brigidi P, Pession A. | Sci Rep | 10.1038/s41598-021-93571-4 | 2021 | ||
| Proteome | Three alginate lyases provide a new gut Bacteroides ovatus isolate with the ability to grow on alginate. | Ronne ME, Tandrup T, Madsen M, Hunt CJ, Myers PN, Moll JM, Holck J, Brix S, Strube ML, Aachmann FL, Wilkens C, Svensson B. | Appl Environ Microbiol | 10.1128/aem.01185-23 | 2023 | |
| Enzymology | Diversity and abundance of single-stranded DNA viruses in human feces. | Kim MS, Park EJ, Roh SW, Bae JW. | Appl Environ Microbiol | 10.1128/aem.06331-11 | 2011 | |
| Metabolism | Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite. | Park SY, Rao C, Coyte KZ, Kuziel GA, Zhang Y, Huang W, Franzosa EA, Weng JK, Huttenhower C, Rakoff-Nahoum S. | Cell | 10.1016/j.cell.2022.01.002 | 2022 | |
| A Putative Type V Pilus Contributes to Bacteroides thetaiotaomicron Biofilm Formation Capacity. | Mihajlovic J, Bechon N, Ivanova C, Chain F, Almeida A, Langella P, Beloin C, Ghigo JM. | J Bacteriol | 10.1128/jb.00650-18 | 2019 | ||
| Metabolism | Ancient acquisition of "alginate utilization loci" by human gut microbiota. | Mathieu S, Touvrey-Loiodice M, Poulet L, Drouillard S, Vincentelli R, Henrissat B, Skjak-Braek G, Helbert W. | Sci Rep | 10.1038/s41598-018-26104-1 | 2018 | |
| Metabolism | Two new xylanases with different substrate specificities from the human gut bacterium Bacteroides intestinalis DSM 17393. | Hong PY, Iakiviak M, Dodd D, Zhang M, Mackie RI, Cann I. | Appl Environ Microbiol | 10.1128/aem.03176-13 | 2014 | |
| Illuminating vital surface molecules of symbionts in health and disease. | Hudak JE, Alvarez D, Skelly A, von Andrian UH, Kasper DL. | Nat Microbiol | 10.1038/nmicrobiol.2017.99 | 2017 | ||
| Metabolism | SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations. | Bustion AE, Nayak RR, Agrawal A, Turnbaugh PJ, Pollard KS. | Elife | 10.7554/elife.82401 | 2023 | |
| Metabolism | A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. | Li W, Hang S, Fang Y, Bae S, Zhang Y, Zhang M, Wang G, McCurry MD, Bae M, Paik D, Franzosa EA, Rastinejad F, Huttenhower C, Yao L, Devlin AS, Huh JR. | Cell Host Microbe | 10.1016/j.chom.2021.07.013 | 2021 | |
| Metabolism | Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome. | Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. | Cell | 10.1016/j.cell.2023.05.037 | 2023 | |
| Eukaryote to gut bacteria transfer of a glycoside hydrolase gene essential for starch breakdown in plants. | Arias MC, Danchin EG, Coutinho P, Henrissat B, Ball S. | Mob Genet Elements | 10.4161/mge.20375 | 2012 | ||
| Enzymology | Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. | Zhang M, Chekan JR, Dodd D, Hong PY, Radlinski L, Revindran V, Nair SK, Mackie RI, Cann I. | Proc Natl Acad Sci U S A | 10.1073/pnas.1406156111 | 2014 | |
| Metabolism | Diversity and abundance of phosphonate biosynthetic genes in nature. | Yu X, Doroghazi JR, Janga SC, Zhang JK, Circello B, Griffin BM, Labeda DP, Metcalf WW. | Proc Natl Acad Sci U S A | 10.1073/pnas.1315107110 | 2013 | |
| Metabolism | Optimized Production of Xylitol from Xylose Using a Hyper-Acidophilic Candida tropicalis. | Tamburini E, Costa S, Marchetti MG, Pedrini P. | Biomolecules | 10.3390/biom5031979 | 2015 | |
| The prevalence of species and strains in the human microbiome: a resource for experimental efforts. | Kraal L, Abubucker S, Kota K, Fischbach MA, Mitreva M. | PLoS One | 10.1371/journal.pone.0097279 | 2014 | ||
| Metabolism | Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks. | Ravcheev DA, Godzik A, Osterman AL, Rodionov DA. | BMC Genomics | 10.1186/1471-2164-14-873 | 2013 | |
| Metabolism | Structure-dependent stimulation of gut bacteria by arabinoxylo-oligosaccharides (AXOS): a review. | Leschonski KP, Mortensen MS, Hansen LBS, Krogh KBRM, Kabel MA, Laursen MF. | Gut Microbes | 10.1080/19490976.2024.2430419 | 2024 | |
| Metabolism | Purification and characterization of phosphonoglycans from Glycomyces sp. strain NRRL B-16210 and Stackebrandtia nassauensis NRRL B-16338. | Yu X, Price NP, Evans BS, Metcalf WW. | J Bacteriol | 10.1128/jb.00036-14 | 2014 | |
| Metabolism | Crystal structures of three representatives of a new Pfam family PF14869 (DUF4488) suggest they function in sugar binding/uptake. | Kumar A, Punta M, Axelrod HL, Das D, Farr CL, Grant JC, Chiu HJ, Miller MD, Coggill PC, Klock HE, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Wilson IA. | Protein Sci | 10.1002/pro.2522 | 2014 | |
| Metabolism | Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. | Tasse L, Bercovici J, Pizzut-Serin S, Robe P, Tap J, Klopp C, Cantarel BL, Coutinho PM, Henrissat B, Leclerc M, Dore J, Monsan P, Remaud-Simeon M, Potocki-Veronese G. | Genome Res | 10.1101/gr.108332.110 | 2010 | |
| Metabolism | Structural and sequence analysis of imelysin-like proteins implicated in bacterial iron uptake. | Xu Q, Rawlings ND, Farr CL, Chiu HJ, Grant JC, Jaroszewski L, Klock HE, Knuth MW, Miller MD, Weekes D, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Wilson IA. | PLoS One | 10.1371/journal.pone.0021875 | 2011 | |
| Metabolism | Biochemical analysis of a beta-D-xylosidase and a bifunctional xylanase-ferulic acid esterase from a xylanolytic gene cluster in Prevotella ruminicola 23. | Dodd D, Kocherginskaya SA, Spies MA, Beery KE, Abbas CA, Mackie RI, Cann IK. | J Bacteriol | 10.1128/jb.01628-08 | 2009 | |
| Metabolism | Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. | Nayak RR, Alexander M, Deshpande I, Stapleton-Gray K, Rimal B, Patterson AD, Ubeda C, Scher JU, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2020.12.008 | 2021 | |
| Design, construction, and in vivo augmentation of a complex gut microbiome. | Cheng AG, Ho PY, Aranda-Diaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, Murugkar P, Patil A, Atabakhsh K, Weakley A, Yan J, Brumbaugh AR, Higginbottom S, Dimas A, Shiver AL, Deutschbauer A, Neff N, Sonnenburg JL, Huang KC, Fischbach MA. | Cell | 10.1016/j.cell.2022.08.003 | 2022 | ||
| Type VI secretion systems of human gut Bacteroidales segregate into three genetic architectures, two of which are contained on mobile genetic elements. | Coyne MJ, Roelofs KG, Comstock LE. | BMC Genomics | 10.1186/s12864-016-2377-z | 2016 | ||
| Genetics | Inter-individual differences in the gene content of human gut bacterial species. | Zhu A, Sunagawa S, Mende DR, Bork P. | Genome Biol | 10.1186/s13059-015-0646-9 | 2015 | |
| Microviridae goes temperate: microvirus-related proviruses reside in the genomes of Bacteroidetes. | Krupovic M, Forterre P. | PLoS One | 10.1371/journal.pone.0019893 | 2011 | ||
| Metabolism | A selective gut bacterial bile salt hydrolase alters host metabolism. | Yao L, Seaton SC, Ndousse-Fetter S, Adhikari AA, DiBenedetto N, Mina AI, Banks AS, Bry L, Devlin AS. | Elife | 10.7554/elife.37182 | 2018 | |
| Enzymology | Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. | Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. | Appl Environ Microbiol | 10.1128/aem.64.9.3336-3345.1998 | 1998 | |
| Enzymology | Domain analysis of a modular alpha-L-Arabinofuranosidase with a unique carbohydrate binding strategy from the fiber-degrading bacterium Fibrobacter succinogenes S85. | Yoshida S, Hespen CW, Beverly RL, Mackie RI, Cann IK. | J Bacteriol | 10.1128/jb.00503-10 | 2010 | |
| Metabolism | Purification and characterization of brochocin A and brochocin B(10-43), a functional fragment generated by heterologous expression in Carnobacterium piscicola. | Garneau S, Ference CA, van Belkum MJ, Stiles ME, Vederas JC. | Appl Environ Microbiol | 10.1128/aem.69.3.1352-1358.2003 | 2003 | |
| Metabolism | Transcriptomic analyses of xylan degradation by Prevotella bryantii and insights into energy acquisition by xylanolytic bacteroidetes. | Dodd D, Moon YH, Swaminathan K, Mackie RI, Cann IK. | J Biol Chem | 10.1074/jbc.m110.141788 | 2010 | |
| Metabolism | Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria. | Alav I, Kobylka J, Kuth MS, Pos KM, Picard M, Blair JMA, Bavro VN. | Chem Rev | 10.1021/acs.chemrev.1c00055 | 2021 | |
| Pathogenicity | In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile. | Mathur T, Barman TK, Kumar M, Singh D, Kumar R, Khera MK, Yamada M, Inoue SI, Upadhyay DJ, Masuda N. | Antimicrob Agents Chemother | 10.1128/aac.02157-17 | 2018 | |
| Genetic Manipulation of Wild Human Gut Bacteroides. | Bencivenga-Barry NA, Lim B, Herrera CM, Trent MS, Goodman AL. | J Bacteriol | 10.1128/jb.00544-19 | 2020 | ||
| Pathogenicity | In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria. | Tanaka K, Mikamo H, Nakao K, Ichiishi T, Goto T, Yamagishi Y, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.00595-08 | 2009 | |
| Pathogenicity | In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria. | Tran CM, Tanaka K, Yamagishi Y, Goto T, Mikamo H, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.01038-10 | 2011 | |
| Phylogeny | Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome. | Whitaker WR, Shepherd ES, Sonnenburg JL. | Cell | 10.1016/j.cell.2017.03.041 | 2017 | |
| Enzymology | pH gradient and distribution of streptococci, lactobacilli, prevotellae, and fusobacteria in carious dentine. | Kianoush N, Nguyen KA, Browne GV, Simonian M, Hunter N. | Clin Oral Investig | 10.1007/s00784-013-1009-0 | 2014 | |
| Pathogenicity | In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone. | Tanaka K, Mikamo H, Nakao K, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.00639-06 | 2006 | |
| Enzymology | Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. | Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. | Appl Environ Microbiol | 10.1128/aem.66.5.2263-2266.2000 | 2000 | |
| Phylogeny | Use of PCR and sodium dodecyl sulfate-polyacrylamide gel electrophoresis techniques for differentiation of Prevotella intermedia sensu stricto and Prevotella nigrescens. | Premaraj T, Kato N, Fukui K, Kato H, Watanabe K. | J Clin Microbiol | 10.1128/jcm.37.4.1057-1061.1999 | 1999 | |
| Phylogeny | Development of cpn60-based real-time quantitative PCR assays for the detection of 14 Campylobacter species and application to screening of canine fecal samples. | Chaban B, Musil KM, Himsworth CG, Hill JE. | Appl Environ Microbiol | 10.1128/aem.00101-09 | 2009 | |
| Development of culture methods capable of culturing a wide range of predominant species of intestinal bacteria. | Hirano R, Nishita I, Nakai R, Bito A, Sasabe R, Kurihara S. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1056866 | 2023 | ||
| Bacteroides eggerthii Ameliorates MASLD through Host-Microbe Signaling and Highlights 2-Hydroxyisocaproate as a Potential Effector. | Choi J, Yoon MG, Jang SH, Baek GO, Jung HS, Lee NR, Lee CH, Han JE, Cheong JY, Eun JW, Kim SS. | Clin Mol Hepatol | 10.3350/cmh.2025.0475 | 2025 | ||
| Causal effects of gut microbiome on aortic dissection: A mendelian randomization study. | Tian Y, Hao F, Xu G, Qian Y, Liu J, Pan N, Yang T. | Clinics (Sao Paulo) | 10.1016/j.clinsp.2025.100811 | 2025 | ||
| Phylogeny | Fecal microbiome associated with egg production efficiency in laying hens. | Chen JW, Wang SY, Yang WY. | Anim Biosci | 10.5713/ab.25.0256 | 2025 | |
| Screening of Fecal Bacteroides Strains and Discovery of Bacteroides eggerthii S13-F8 with Protective Effects Against Chemotherapy-Induced Diarrhea. | Zhao Y, Dai Z, Lang Y, Li R, Zheng H, Mi J, He X, Liu J, Xiang R, Mei X, Liu Y, Wang Y, Guo H, Yang Q, Ren K, Yang T. | Probiotics Antimicrob Proteins | 10.1007/s12602-025-10595-2 | 2025 | ||
| Pathogenicity | The Role of 473 Intestinal Microbiota and 91 Inflammatory Factors in Breast Cancer Risk: Insights From Mendel Randomization and its Implications for Diagnosis and Treatment. | Zhu R, Qiu J, Xian D, Yang K. | Clin Breast Cancer | 10.1016/j.clbc.2025.06.001 | 2025 | |
| The human gut Bacteroides eggerthii expresses a new galactofuranose-containing lipooligosaccharide with weak immunostimulatory properties | Tiemblo Martin M, Coccimiglio M, Andretta E, De Simone Carone L, Bell A, Gerpe-Amor T, Di Carluccio C, Molinaro A, van Kooyk Y, Juge N, Chiodo F, Di Lorenzo F, Silipo A. | Carbohydrate polymers. | 2025 | |||
| The human gut Bacteroides eggerthii expresses a new galactofuranose-containing lipooligosaccharide with weak immunostimulatory properties. | Tiemblo Martin M, Coccimiglio M, Andretta E, De Simone Carone L, Bell A, Gerpe-Amor T, Di Carluccio C, Molinaro A, van Kooyk Y, Juge N, Chiodo F, Di Lorenzo F, Silipo A. | Carbohydr Polym | 10.1016/j.carbpol.2024.122833 | 2025 | ||
| Pathogenicity | Gut microbiota alterations and their association with tumorigenic pathways in colorectal cancer: insights from a pooled analysis of 109 microbiome datasets. | Haque S, Bantun F, Jalal NA, Faidah H, Babalghith AO, Alobaidy MA, Aldairi AF, Ahmad F. | Gut Pathog | 10.1186/s13099-025-00712-5 | 2025 | |
| Maillard conjugates of whey protein isolate and gum Arabic: Enhanced functional properties and unique gut microbiota regulation | Kan X, Zhang K, Fan X, Chen L, Zeng X. | Food hydrocolloids. | 2024 | |||
| Analysis of Gut Microbiota and Their Metabolites in CADASIL Patients. | Watanabe-Hosomi A, Inoue R, Mizuta I, Matsuura J, Matsuura H, Fukunaga D, Ohara T, Naito Y, Mizuno T. | J Clin Neurol | 10.3988/jcn.2025.0231 | 2025 | ||
| Mediators linking gut microbiota and sporadic Creutzfeldt-Jakob disease: a Mendelian randomization study. | Shao J, Su T, Wang J, Yin X, Lang Y, Fu Y, Cui L. | AMB Express | 10.1186/s13568-025-01932-3 | 2025 | ||
| Exploring the Interplay Between Gut Microbiota and the Melatonergic Pathway in Hormone Receptor-Positive Breast Cancer. | Laborda-Illanes A, Boutriq S, Aranega-Martin L, Castellano-Castillo D, Sanchez-Alcoholado L, Plaza-Andrades I, Peralta-Linero J, Alba E, Fernandez-Garcia JC, Gonzalez-Gonzalez A, Queipo-Ortuno MI. | Int J Mol Sci | 10.3390/ijms26146801 | 2025 | ||
| [Faecal microbiota study reveals specific dysbiosis in spondyloarthritis according to subtype, disease activity and treatment]. | Romero-Sanchez C, Ferrer-Santos C, Abril D, Acosta-Hernandez E, Avila J, Ramos-Casallas A, Escobar J, Bautista-Molano W, Jaimes D, Beltran-Ostos A, Bello-Gualtero JM, Florez-Sarmiento C, Parra-Izquierdo V, Calixto OJ. | Rev Alerg Mex | 10.29262/ram.v71i1.1305 | 2024 | ||
| Transcriptome | Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients. | Yu L, Chen X, Bai X, Fang J, Sui M. | Mol Neurobiol | 10.1007/s12035-023-03744-7 | 2024 | |
| Healthy Ageing and Gut Microbiota: A Study on Longevity in Adults. | Deng L, Xu J, Xue Q, Wei Y, Wang J. | Microorganisms | 10.3390/microorganisms13071657 | 2025 | ||
| Gut microbiota characterization in ageing, mild cognitive impairment, and Alzheimer's disease in the context of mediterranean lifestyle in a Spanish population. | Cabrera C, Carrion N, Mateo D, Vicens P, Pinzon A, Heredia L, Forcadell-Ferreres E, Pino M, Yerga B, Zaragoza J, Vicente-Pascual M, Moral A, Arco T, Arjo M, Martinez E, Galvez S, Lozano MJ, Torrente M. | Alzheimers Res Ther | 10.1186/s13195-025-01862-z | 2025 | ||
| Exploring the role of acylated ghrelin and gut microbiome in delineating cognitive health in the elderly. | Rout S, Dash R, Satish V, Venugopal G, Rao BN, Bandhyopadhyay D, Bhoi SK, Ramadass B. | Aging (Albany NY) | 10.18632/aging.206200 | 2025 | ||
| Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial. | Wong MK, Armstrong E, Heirali AA, Schneeberger PHH, Chen H, Cochrane K, Sherriff K, Allen-Vercoe E, Siu LL, Spreafico A, Coburn B. | mBio | 10.1128/mbio.01904-25 | 2025 | ||
| Modulation of Gut Microbiota by Whole Encapsulated Brown Seaweed (Himanthalia elongata) in Overweight Subjects: A Randomized Double-Blind Placebo-Controlled Trial. | Lopez-Santamarina A, Cardelle-Cobas A, Mondragon ADC, Cepeda A, Rodriguez JA, Miranda JM. | Nutrients | 10.3390/nu17122047 | 2025 | ||
| Red meat consumption in higher healthy eating index diets is associated with brain health critical nutritional adequacy, and fecal microbial diversity. | Dhakal S, Hossain M, Parajuli S. | Sci Rep | 10.1038/s41598-025-18907-w | 2025 | ||
| Phylogeny | Exploring the Intestinal Microbiota Profile in Prostate Cancer Patients and Healthy Controls. | Cocomazzi G, Villani A, Mencarelli G, Contu V, De Ruvo D, Virgili E, Marino F, Baldini GM, Binda E, Parmegiani L, Ciampaglia W, Capone L, Perri F, Cisternino A, Pazienza V, Panebianco C. | Microorganisms | 10.3390/microorganisms13092105 | 2025 | |
| Circulating Inflammatory Proteins Mediate the Causal Effect of Gut Microbiota on Inflammatory Bowel Disease: Bayesian and Mediated Mendelian Randomization. | Li Z, Jia L, Huai S. | FASEB Bioadv | 10.1096/fba.2025-00114 | 2025 | ||
| The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies. | Kang Y, Cai Y, Zhao Y, Yang Y. | Front Nutr | 10.3389/fnut.2022.979876 | 2022 | ||
| Genetics | Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer's disease pathology. | Fan KC, Lin CC, Chiu YL, Koh SH, Liu YC, Chuang YF. | Alzheimers Res Ther | 10.1186/s13195-025-01769-9 | 2025 | |
| Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study. | Tian Y, Zhao R, Xiao S, Chen L, Cheng Y, Meng W, Tang Z, Cai Y, Xiao Z, Yi A, Chen M, Zhao X, Ruan G, Wei Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1524987 | 2025 | ||
| 1H, 13C, 15N resonance assignment of the enzyme KdgF from Bacteroides eggerthii. | Petersen AB, Christensen IA, Ronne ME, Stender EGP, Teze D, Svensson B, Aachmann FL. | Biomol NMR Assign | 10.1007/s12104-022-10102-6 | 2022 | ||
| The Bacterial Composition of the Gut Microbiota of Mexicans with Overweight and Obesity: A Systematic Review | Samudio-Cruz M, Luna-Angulo A, Cabrera-Ruiz E, Landa-Solis C, Rangel-Lopez E, Carrillo-Mora P, Rios-Martinez J, Toledo-Perez R, Paniagua-Perez R, Martinez-Canseco C, Lino-Gonzalez A, Saldana Solano A, Sanchez-Chapul L. | Microorganisms | 2025 | |||
| Phylogeny | Peritonitis with bacteremia due to Christensenella hongkongensis identified via ribosomal RNA sequencing in a Japanese patient with advanced colorectal adenocarcinoma: A case report. | Itoh N, Akazawa N, Ishibana Y, Murakami H. | IDCases | 10.1016/j.idcr.2023.e01797 | 2023 | |
| Safety, Tolerability, and Immunogenicity of a DNA Vaccine (pGX9501) Against SARS-CoV-2 in Healthy Volunteers: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, and Dose-Ranging Phase I Trial. | Yang H, Zhou Y, Cheng X, Qiu C, Wang S, Xia Y, Huai X, Xiu Z, Wang J, He Y, Cao G, Wei Q, Wang J, Ai J, Zhang H, Zhang Y, Zhang J, Zhang W, Wang B. | Vaccines (Basel) | 10.3390/vaccines13060573 | 2025 | ||
| Systematic review of bidirectional interaction between gut microbiome, miRNAs, and human pathologies. | Drago L, De La Motte LR, Deflorio L, Sansico DF, Salvatici M, Micaglio E, Biazzo M, Giarritiello F. | Front Microbiol | 10.3389/fmicb.2025.1540943 | 2025 | ||
| The Efficacy of Cheonggukjang in Alleviating Menopausal Syndrome and Its Effects on the Gut Microbiome: A Randomized, Double-Blind Trial. | Han AL, Ryu MS, Yang HJ, Jeong DY, Choi KH. | Nutrients | 10.3390/nu17030505 | 2025 | ||
| The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac. | Ng HY, Liao Y, Zhang R, Chan KH, To WP, Hui CH, Seto WK, Leung WK, Hung IFN, Lam TTY, Cheung KS. | Int J Mol Sci | 10.3390/ijms25052583 | 2024 | ||
| MicroSTNet: a spatio-temporal graph-based framework for time-series microbiome analysis. | Gao S, Li L, Wang J, Wang Y, Dong Y. | Microb Genom | 10.1099/mgen.0.001519 | 2025 | ||
| Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease. | Kozhakhmetov S, Kaiyrlykyzy A, Jarmukhanov Z, Vinogradova E, Zholdasbekova G, Alzhanova D, Kunz J, Kushugulova A, Askarova S. | Int J Alzheimers Dis | 10.1155/2024/9741811 | 2024 | ||
| Genetics | The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation. | Xiao L, Liu S, Wu Y, Huang Y, Tao S, Liu Y, Tang Y, Xie M, Ma Q, Yin Y, Dai M, Zhang M, Llamocca E, Gui H, Wang Q. | Brain Behav Immun | 10.1016/j.bbi.2023.08.003 | 2023 | |
| Concomitant decrease of double-positive lymphocyte population CD4CD8alphaalpha and Faecalibacterium prausnitzii in patients with colorectal cancer. | Touchefeu Y, Duchalais E, Bruley des Varannes S, Alameddine J, Mirallie E, Matysiak-Budnik T, Le Bastard Q, Javaudin F, Rimbert M, Jotereau F, Montassier E. | Eur J Gastroenterol Hepatol | 10.1097/meg.0000000000001842 | 2021 | ||
| Gut microbiome is associated with asthma and race in children with food allergy. | Mahdavinia M, Fyolek JP, Jiang J, Thivalapill N, Bilaver LA, Warren C, Fox S, Nimmagadda SR, Newmark PJ, Sharma H, Assa'ad A, Seed PC, Gupta RS. | J Allergy Clin Immunol | 10.1016/j.jaci.2023.07.024 | 2023 | ||
| Gut microbiota influences lung cancer risk through circulating cytokines-Insights from a Mendelian randomization study. | Shen W, Hou R, Zhang J, Liu C, Zhang C, Liu X. | Medicine (Baltimore) | 10.1097/md.0000000000044897 | 2025 | ||
| Metabolism | Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS). | Shin AS, Xing Y, Waseem MR, Siwiec R, James-Stevenson T, Rogers N, Bohm M, Wo J, Lockett C, Gupta A, Kadariya J, Toh E, Anderson R, Dong A, Xu H, Gao X. | Sci Rep | 10.1038/s41598-025-19363-2 | 2025 | |
| Age-related Eye Disease Studies Supplements and Genetic Risk Score Are Crucial Determinants of Intestinal Microbial Alterations in Advanced Age-Related Macular Degeneration. | Dadgar N, Fung K, McClintic S, Metea C, Llorenc V, Saleh M, Nakamura YK, Jahrig C, Kiang L, Janowitz C, Davin S, Balter A, Le Cao KA, Karstens L, Martin TM, Klein ML, Lin P. | Ophthalmol Sci | 10.1016/j.xops.2025.100920 | 2026 | ||
| Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers. | Moreno-Arrones OM, Serrano-Villar S, Perez-Brocal V, Saceda-Corralo D, Morales-Raya C, Rodrigues-Barata R, Moya A, Jaen-Olasolo P, Vano-Galvan S. | J Eur Acad Dermatol Venereol | 10.1111/jdv.15885 | 2020 | ||
| Genetics | Alterations of Gut Microbiome in Patients with Colorectal Advanced Adenoma by Metagenomic Analyses. | Xiang J, Chai N, Li L, Hao X, Linghu E. | Turk J Gastroenterol | 10.5152/tjg.2024.24294 | 2024 | |
| Gut microbiota-derived 4-hydroxyphenylacetic acid (4-HPAA) inhibits weight gain and is negatively associated with childhood obesity. | Li Q, Zhang J, Fan M, Wu N, Li T, Wang M, Zhang L. | Transl Pediatr | 10.21037/tp-2025-158 | 2025 | ||
| Identifying microbial signatures for patients with postmenopausal osteoporosis using gut microbiota analyses and feature selection approaches. | Huang D, Wang J, Zeng Y, Li Q, Wang Y. | Front Microbiol | 10.3389/fmicb.2023.1113174 | 2023 | ||
| Gut microbiome and metabolome profiles in renal allograft rejection from multiomics integration. | Dai X, Cao Y, Li L, Gao Y-X, Wang J-X, Liu Y-J, Ma T-T, Zheng J-M, Zhan P-P, Shen Z-Y. | mSystems | 10.1128/msystems.01626-24 | 2025 | ||
| Microbial Ecosystem Therapeutics 4 (MET4) elicits treatment-specific IgG responses associated with changes in gut microbiota in immune checkpoint inhibitor recipients with advanced solid tumors. | Wong MK, Boukhaled GM, Armstrong E, Liu R, Heirali AA, Yee NR, Tsang J, Spiliopoulou P, Schneeberger PHH, Wang BX, Cochrane K, Sherriff K, Allen-Vercoe E, Siu LL, Spreafico A, Coburn B. | J Immunother Cancer | 10.1136/jitc-2024-010681 | 2025 | ||
| Genetics | Infectious Keratitis: Characterization of Microbial Diversity through Species Richness and Shannon Diversity Index. | Schiano-Lomoriello D, Abicca I, Contento L, Gabrielli F, Alfonsi C, Di Pietro F, Papa FT, Ballesteros-Sanchez A, Sanchez-Gonzalez JM, Rocha-De-Lossada C, Mazzotta C, Giannaccare G, Bonzano C, Borroni D. | Biomolecules | 10.3390/biom14040389 | 2024 | |
| Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale. | Zhang W, Al Tekreeti T, Leung PSC, Tsuneyama K, Dhillon H, Rojas M, Heuer LS, Ridgway WM, Ansari AA, Young HA, Mackay CR, Gershwin ME. | Liver Int | 10.1111/liv.16060 | 2024 | ||
| Fecal Microbiota Transplantation Induces Sustained Gut Microbiome Changes in Pediatric Ulcerative Colitis: A Combined Randomized and Open-Label Study. | Le J, Hakimjavadi H, Parsana R, Chamala S, Michail S. | Gastro Hep Adv | 10.1016/j.gastha.2025.100741 | 2025 | ||
| Phylogeny | The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination. | Tarrino M, Gutierrez-Bautista JF, Duran MJO, Garcia-Diaz A, Cabrera-Serrano AJ, Sainz J, Cobo F, Rodriguez T, Reguera JA, Bernal M, Lopez-Nevot MA, Sampedro A. | Sci Rep | 10.1038/s41598-025-11103-w | 2025 | |
| Genetics | The Relationship Between Osteoporosis and Intestinal Microbes in the Henan Province of China. | Qin Q, Yan S, Yang Y, Chen J, Yan H, Li T, Gao X, Wang Y, Li A, Wang S, Ding S. | Front Cell Dev Biol | 10.3389/fcell.2021.752990 | 2021 | |
| Mendelian randomization study revealed a gut microbiota-immune system-kidney junction axis in chronic kidney disease. | Tan J, Xiong Z, Yu S, Lu W, Yu L. | Sci Rep | 10.1038/s41598-025-05941-x | 2025 | ||
| Enzymology | Efficacy of Lacticaseibacillus rhamnosus probiotic strains in treating chromate induced dermatitis. | Ali M, Amin A, Abbas Z. | Sci Rep | 10.1038/s41598-025-93732-9 | 2025 | |
| Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors. | Lin A, Huang L, Jiang A, Zhu L, Mou W, Li Y, Zhang C, Liu Z, Zhang J, Cheng Q, Wei T, Luo P. | BMC Med | 10.1186/s12916-025-04183-y | 2025 | ||
| Biotransformation of quercetin by Bacillus subtilis and anticancer activity evaluation: in vitro and in Silico. | El Gendy SN, Elmotayam AK, Samir R, Ezzat MI, Abo-Elfadl MT, El Sayed AM. | AMB Express | 10.1186/s13568-025-01860-2 | 2025 | ||
| Neutrophil-to-Lymphocyte Ratio at Diagnosis Predicts Colonoscopic Activity in Pediatric Inflammatory Bowel Diseases. | Aziz B, Aziz B, Belaghi R, Huynh H, Jacobson K, Mack DR, Deslandres C, Otley A, DeBruyn J, El-Matary W, Crowley E, Sherlock M, Critch J, Ahmed N, Griffiths A, Walters T, Wine E, Canadian Children IBD Network. | Clin Transl Gastroenterol | 10.14309/ctg.0000000000000824 | 2025 | ||
| Fecal Microbiota Transplantation May Represent a Good Approach for Patients with Focal Segmental Glomerulosclerosis: A Brief Report. | Zhi W, Yuan X, Song W, Jin G, Li Y. | J Clin Med | 10.3390/jcm11226700 | 2022 | ||
| Mediation effect of gut microbiota on the relationship between physical activity and carotid plaque. | Ouyang W, Tang B, He Y, Wu H, Yang P, Yin L, Li X, Li Y, Huang X. | Front Microbiol | 10.3389/fmicb.2024.1432008 | 2024 | ||
| Temporal network analysis of gut microbiota unveils aging trajectories associated with colon cancer. | Chen Z, Zhang Z, Nie BN, Huang W, Zhu Y, Zhang L, Xu M, Wang M, Yuan C, Liu N, Wang X, Tian J, Ba Q, Wang Z. | mSystems | 10.1128/msystems.01188-24 | 2025 | ||
| Pathogenicity | Modified Zhujing pill regulates RPE cholesterol metabolism and gut microbiota in an age-related macular degeneration mouse model. | Cen S, Xie S, Ibrahim KS, Baran MR, Li X, Reilly J, Tan Z, He Z, Shu X. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1691360 | 2025 | |
| Immunomodulatory Role of Vitamin D on Gut Microbiome in Children. | Tabassum A, Ali A, Zahedi FD, Ismail NAS. | Biomedicines | 10.3390/biomedicines11051441 | 2023 | ||
| Mucosal homeostasis is altered in the ileum of gnotobiotic mice. | Greig CJ, Alper A, Goodman AL, Cowles RA. | J Surg Res | 10.1016/j.jss.2018.05.055 | 2018 | ||
| Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review. | Lim MY, Hong S, Nam YD. | Front Immunol | 10.3389/fimmu.2024.1512683 | 2024 | ||
| Exploring Gut Microbiota and the Influence of Physical Activity Interventions on Overweight and Obese Children and Adolescents: A Systematic Review. | Morgado MC, Sousa M, Coelho AB, Costa JA, Seabra A. | Healthcare (Basel) | 10.3390/healthcare11172459 | 2023 | ||
| Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of International Studies. | Hsu CK, Su SC, Chang LC, Shao SC, Yang KJ, Chen CY, Chen YT, Wu IW. | Int J Med Sci | 10.7150/ijms.66451 | 2021 | ||
| Effects of OsomeFood Clean Label plant-based meals on the gut microbiome. | Jacky D, Bibi C, Meng LMC, Jason F, Gwendoline T, Jeremy L, Wie CC. | BMC Microbiol | 10.1186/s12866-023-02822-z | 2023 | ||
| Phylogeny | Stressful events induce long-term gut microbiota dysbiosis and associated post-traumatic stress symptoms in healthcare workers fighting against COVID-19. | Gao F, Guo R, Ma Q, Li Y, Wang W, Fan Y, Ju Y, Zhao B, Gao Y, Qian L, Yang Z, He X, Jin X, Liu Y, Peng Y, Chen C, Chen Y, Gao C, Zhu F, Ma X. | J Affect Disord | 10.1016/j.jad.2022.02.024 | 2022 | |
| Investigating volatile compounds in the Bacteroides secretome. | Shagaleeva OY, Kashatnikova DA, Kardonsky DA, Konanov DN, Efimov BA, Bagrov DV, Evtushenko EG, Chaplin AV, Silantiev AS, Filatova JV, Kolesnikova IV, Vanyushkina AA, Stimpson J, Zakharzhevskaya NB. | Front Microbiol | 10.3389/fmicb.2023.1164877 | 2023 | ||
| Machine learning framework for gut microbiome biomarkers discovery and modulation analysis in large-scale obese population. | Liu Y, Zhu J, Wang H, Lu W, Lee YK, Zhao J, Zhang H. | BMC Genomics | 10.1186/s12864-022-09087-2 | 2022 | ||
| Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo. | De Bruyn F, James K, Cottenet G, Dominick M, Katja J. | Commun Biol | 10.1038/s42003-024-06628-1 | 2024 | ||
| Big data analytics frameworks for the influence of gut microbiota on the development of tic disorder. | Fan F, Bian Z, Zhang X, Wu H, Wang S, Zhang S, Wang Q, Han F. | Front Comput Neurosci | 10.3389/fncom.2022.986591 | 2022 | ||
| Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes. | Sasidharan Pillai S, Gagnon CA, Foster C, Ashraf AP. | J Clin Endocrinol Metab | 10.1210/clinem/dgae499 | 2024 | ||
| Correlation of Gut Microbiota with Children Obesity and Weight Loss. | Peng LJ, Chen YP, Qu F, Zhong Y, Jiang ZS. | Indian J Microbiol | 10.1007/s12088-023-01088-3 | 2024 | ||
| Evaluation of the gut microbiome associated with COVID-19. | Maddah R, Goodarzi V, Asadi-Yousefabad SL, Abbasluo M, Shariati P, Shafiei Kafraj A. | Inform Med Unlocked | 10.1016/j.imu.2023.101239 | 2023 | ||
| Metabolism | In vitro gut microbiome response to carbohydrate supplementation is acutely affected by a sudden change in diet. | Pantoja-Feliciano IG, Karl JP, Perisin M, Doherty LA, McClung HL, Armstrong NJ, Renberg R, Racicot K, Branck T, Arcidiacono S, Soares JW. | BMC Microbiol | 10.1186/s12866-023-02776-2 | 2023 | |
| Pathogenicity | Structure analysis of human gut microbiota associated with single-celled gut protists using Next-Generation Sequencing of 16S and 18S rRNA genes. | Belkessa S, Pasolli E, Medrouh B, Berg RPKD, Andersen LO', Nielsen HV, Stensvold CR. | Comput Struct Biotechnol J | 10.1016/j.csbj.2025.06.006 | 2025 | |
| Metabolism | Characterization of a novel multidomain CE15-GH8 enzyme encoded by a polysaccharide utilization locus in the human gut bacterium Bacteroides eggerthii. | Kmezik C, Krska D, Mazurkewich S, Larsbrink J. | Sci Rep | 10.1038/s41598-021-96659-z | 2021 | |
| Pathogenicity | A Citrus Fruit Extract High in Polyphenols Beneficially Modulates the Gut Microbiota of Healthy Human Volunteers in a Validated In Vitro Model of the Colon. | Sost MM, Ahles S, Verhoeven J, Verbruggen S, Stevens Y, Venema K. | Nutrients | 10.3390/nu13113915 | 2021 | |
| Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials. | Jeyaraman N, Jeyaraman M, Mariappan T, Muthu S, Ramasubramanian S, Sharma S, Santos GS, da Fonseca LF, Lana JF. | World J Gastrointest Pharmacol Ther | 10.4292/wjgpt.v15.i6.98146 | 2024 | ||
| Genetics | Mendelian randomization analyses support causal relationships between gut microbiome and longevity. | Chen S, Chen W, Wang X, Liu S. | J Transl Med | 10.1186/s12967-024-05823-2 | 2024 | |
| Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease Management. | Blondeaux A, Valibouze C, Speca S, Rousseaux C, Dubuquoy C, Blanquart H, Zerbib P, Desreumaux P, Foligne B, Titecat M. | Int J Mol Sci | 10.3390/ijms25042164 | 2024 | ||
| Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus. | Han CY, Ye XM, Lu JP, Jin HY, Wang P, Xu WW, Zhang M. | Diabetes Metab Syndr Obes | 10.2147/dmso.s418757 | 2023 | ||
| Metabolism | Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer. | Zou S, Yang C, Zhang J, Zhong D, Meng M, Zhang L, Chen H, Fang L. | J Transl Med | 10.1186/s12967-024-04984-4 | 2024 | |
| Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits. | Lopez-Contreras BE, Moran-Ramos S, Villarruel-Vazquez R, Macias-Kauffer L, Villamil-Ramirez H, Leon-Mimila P, Vega-Badillo J, Sanchez-Munoz F, Llanos-Moreno LE, Canizalez-Roman A, Del Rio-Navarro B, Ibarra-Gonzalez I, Vela-Amieva M, Villarreal-Molina T, Ochoa-Leyva A, Aguilar-Salinas CA, Canizales-Quinteros S. | Pediatr Obes | 10.1111/ijpo.12262 | 2018 | ||
| Evaluating the Effects of Sugar Shift® Symbiotic on Microbiome Composition and LPS Regulation: A Double-Blind, Placebo-Controlled Study. | Garcia G, Soto J, Netherland M, Hasan NA, Buchaca E, Martinez D, Carlin M, de Jesus Cano R. | Microorganisms | 10.3390/microorganisms12122525 | 2024 | ||
| Dietary supplementary with ellagic acid improves the intestinal barrier function and flora structure of broiler chicken challenged with E. coli K88. | Li P, Zhao S, Teng Y, Han S, Yang Y, Wu M, Guo S, Ding B, Xiao L, Yi D. | Poult Sci | 10.1016/j.psj.2024.104429 | 2024 | ||
| Genetics | Metagenome-assembled microbial genomes from Parkinson's disease fecal samples. | Duru IC, Lecomte A, Shishido TK, Laine P, Suppula J, Paulin L, Scheperjans F, Pereira PAB, Auvinen P. | Sci Rep | 10.1038/s41598-024-69742-4 | 2024 | |
| The Relationship Between Gut Microbiome and Ophthalmologic Diseases: A Comprehensive Review. | Lima Barrientos J, Rojas Huerta A, Perez Mendoza A, Abreu Lopez BA, Salolin Vargas VP, Garcia Gonzalez OY, Saldana Ruiz MA, Diarte E, Torijano Sarria AJ. | Cureus | 10.7759/cureus.66808 | 2024 | ||
| Exploring the Relationship between Gut Microbiome Composition and Blood Indole-3-acetic Acid in Hemodialysis Patients. | Wu PH, Tseng YF, Liu W, Chuang YS, Tai CJ, Tung CW, Lai KY, Kuo MC, Chiu YW, Hwang SJ, Hung WC, Lin YT. | Biomedicines | 10.3390/biomedicines12010148 | 2024 | ||
| Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. | Vernaci G, Savarino EV, Patuzzi I, Facchin S, Zingone F, Massa D, Faggioni G, Giarratano T, Miglietta F, Griguolo G, Fassan M, Lo Mele M, Gasparini E, Bisagni G, Guarneri V, Dieci MV. | Oncologist | 10.1093/oncolo/oyad060 | 2023 | ||
| Quantitative differences in synthetic gut microbial inoculums do not affect the final stabilized in vitro community compositions. | Gnanasekaran T, Sarathi A, Fang Q, Azarm A, Assis Geraldo J, Nigro E, Arumugam M. | mSystems | 10.1128/msystems.01249-22 | 2023 | ||
| Influence of saccharide modifications on heparin lyase III substrate specificities. | Wu J, Chopra P, Boons GJ, Zaia J. | Glycobiology | 10.1093/glycob/cwab023 | 2022 | ||
| Deciphering the Physiological Responses to the Intake of Plant-Based Meat Analogues: On the Track of Microbiota and Biomarkers in Serum and Urine. | Sanchez-Terron G, Martinez R, Morcuende D, Estevez M. | J Agric Food Chem | 10.1021/acs.jafc.5c02799 | 2025 | ||
| Evaluation of Menopausal Syndrome Relief and Anti-Obesity Efficacy of the Korean Fermented Food Doenjang: A Randomized, Double-Blind Clinical Trial. | Han AL, Ryu MS, Yang HJ, Jeong DY, Choi KH. | Nutrients | 10.3390/nu16081194 | 2024 | ||
| High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. | Anderson BD, Sepulveda DE, Nachnani R, Cortez-Resendiz A, Coates MD, Beckett A, Bisanz JE, Kellogg JJ, Raup-Konsavage WM. | J Pharmacol Exp Ther | 10.1124/jpet.124.002204 | 2024 | ||
| Association of Gut Microbiota with Age-Related Macular Degeneration and Glaucoma: A Bidirectional Mendelian Randomization Study. | Li C, Lu P. | Nutrients | 10.3390/nu15214646 | 2023 | ||
| Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study. | Khattab RH, Abo-Hammam RH, Salah M, Hanora AM, Shabayek S, Zakeer S. | BMC Microbiol | 10.1186/s12866-023-02991-x | 2023 | ||
| Pathogenicity | Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis. | Wang RX, Zhou HB, Gao JX, Li XH, Bai WF, Wang J, Bai YC, Fan LY, Chang H, Shi SL. | Front Med (Lausanne) | 10.3389/fmed.2025.1489100 | 2025 | |
| Phylogeny | Comprehensive analyses of a large human gut Bacteroidales culture collection reveal species- and strain-level diversity and evolution. | Zhang ZJ, Cole CG, Coyne MJ, Lin H, Dylla N, Smith RC, Pappas TE, Townson SA, Laliwala N, Waligurski E, Ramaswamy R, Woodson C, Burgo V, Little JC, Moran D, Rose A, McMillin M, McSpadden E, Sundararajan A, Sidebottom AM, Pamer EG, Comstock LE. | Cell Host Microbe | 10.1016/j.chom.2024.08.016 | 2024 | |
| Phylogeny | Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study. | De Caro C, Spagnuolo R, Quirino A, Mazza E, Carrabetta F, Maurotti S, Cosco C, Bennardo F, Roberti R, Russo E, Giudice A, Giudice A, Pujia A, Doldo P, Matera G, Marascio N. | Int J Mol Sci | 10.3390/ijms25105453 | 2024 | |
| Aged Gut Microbiota Contributes to Cognitive Impairment and Hippocampal Synapse Loss in Mice. | Li M, Ren J, Bao Y, Wei W, Yu X, He X, Gulisima M, Sheng L, Zheng N, Wan J, Zhou H, Zhao L, Li H. | Aging Cell | 10.1111/acel.70064 | 2025 | ||
| Exploration of three Dyadobacter fermentans enzymes uncovers molecular activity determinants in CE15. | Carbonaro M, Mazurkewich S, Fiorentino G, Lo Leggio L, Larsbrink J. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13175-6 | 2024 | ||
| Exploring the Dynamic Relationship between the Gut Microbiome and Body Composition across the Human Lifespan: A Systematic Review. | Komodromou I, Andreou E, Vlahoyiannis A, Christofidou M, Felekkis K, Pieri M, Giannaki CD. | Nutrients | 10.3390/nu16050660 | 2024 | ||
| Enzymology | Exploring bacterial heparinase II activities with defined substrates. | Bohlmann L, Chang CW, Beacham I, von Itzstein M. | Chembiochem | 10.1002/cbic.201500081 | 2015 | |
| Citrus Extract High in Flavonoids Beneficially Alters Intestinal Metabolic Responses in Subjects with Features of Metabolic Syndrome. | Maurer Sost M, Stevens Y, Salden B, Troost F, Masclee A, Venema K. | Foods | 10.3390/foods12183413 | 2023 | ||
| Gut Microbiome Composition in Dystonia Patients. | Timmers ER, Swarte JC, Gacesa R, Bjork JR, Weersma RK, Tijssen MAJ, de Koning TJ, Harmsen HJM, Niezen-Koning KE. | Int J Mol Sci | 10.3390/ijms24032383 | 2023 | ||
| Enzymology | Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. | Lv LX, Fang DQ, Shi D, Chen DY, Yan R, Zhu YX, Chen YF, Shao L, Guo FF, Wu WR, Li A, Shi HY, Jiang XW, Jiang HY, Xiao YH, Zheng SS, Li LJ. | Environ Microbiol | 10.1111/1462-2920.13401 | 2016 | |
| Integrating Choline and Specific Intestinal Microbiota to Classify Type 2 Diabetes in Adults: A Machine Learning Based Metagenomics Study. | Zeng Q, Zhao M, Wang F, Li Y, Li H, Zheng J, Chen X, Zhao X, Ji L, Gao X, Liu C, Wang Y, Cheng S, Xu J, Pan B, Sun J, Li Y, Li D, He Y, Zheng L. | Front Endocrinol (Lausanne) | 10.3389/fendo.2022.906310 | 2022 | ||
| Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts. | Vinogradova E, Mukhanbetzhanov N, Nurgaziyev M, Jarmukhanov Z, Aipova R, Sailybayeva A, Bekbossynova M, Kozhakhmetov S, Kushugulova A. | mSystems | 10.1128/msystems.00585-24 | 2024 | ||
| Genetics | Effect of time-restricted eating regimen on weight loss is mediated by gut microbiome. | Huang C, Liu D, Yang S, Huang Y, Wei X, Zhang P, Lin J, Xu B, Liu Y, Guo D, Li Y, Li J, Zhang H. | iScience | 10.1016/j.isci.2024.110202 | 2024 | |
| Impact of cigarette smoking on gut microbial dysbiosis: a structured literature review. | Imade EE, Obayagbona NO. | Gut Microbiome (Camb) | 10.1017/gmb.2024.3 | 2024 | ||
| Phylogeny | Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls. | Senthakumaran T, Moen AEF, Tannaes TM, Endres A, Brackmann SA, Rounge TB, Bemanian V, Tunsjo HS. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-023-04551-7 | 2023 | |
| Alterations of the Gut Microbiome Associated to Methane Metabolism in Mexican Children with Obesity. | Murga-Garrido SM, Orbe-Orihuela YC, Diaz-Benitez CE, Castaneda-Marquez AC, Cornejo-Granados F, Ochoa-Leyva A, Sanchez-Flores A, Cruz M, Burguete-Garcia AI, Lagunas-Martinez A. | Children (Basel) | 10.3390/children9020148 | 2022 | ||
| Novel Thermostable Heparinase Based on the Genome of Bacteroides Isolated from Human Gut Microbiota. | Zhang C, Yu L, Zhai Q, Zhao R, Wang C, Zhao J, Zhang H, Chen W, Tian F. | Foods | 10.3390/foods11101462 | 2022 | ||
| Silk-derived sericin/fibroin mixture drink fermented with plant-derived Lactococcus lactis BM32-1 improves constipation and related microbiota: a randomized, double-blind, and placebo-controlled clinical trial. | Noda M, Danshiitsoodol N, Kanno K, Sugiyama M. | Biosci Microbiota Food Health | 10.12938/bmfh.2023-102 | 2024 | ||
| Association between Neutrophil-to-Lymphocyte Ratio and Gut Microbiota in a Large Population: a Retrospective Cross-Sectional Study. | Yoon HY, Kim HN, Lee SH, Kim SJ, Chang Y, Ryu S, Shin H, Kim HL, Lee JH. | Sci Rep | 10.1038/s41598-018-34398-4 | 2018 | ||
| Genetics | Antibiotic resistance profiles of gut microbiota across various primate species in Guangxi. | Huang H, Pang X, Que T, Chen P, Li S, Wu A, He M, Qiu H, Hu Y. | Front Microbiol | 10.3389/fmicb.2023.1309709 | 2023 | |
| The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). | Mohamed A, Asa SL, McCormick T, Al-Shakhshir H, Dasari A, Mauricio R, Salem I, Ocuin LM, Bajor D, Lee RT, Selfridge JE, Kardan A, Lee Z, Avril N, Kopp S, Winter JM, Hardacre JM, Ammori JB, Ghannoum MA. | Curr Issues Mol Biol | 10.3390/cimb44050136 | 2022 | ||
| Gut Microbiome Alterations in Patients With Carotid Atherosclerosis. | Chen J, Qin Q, Yan S, Yang Y, Yan H, Li T, Wang L, Gao X, Li A, Ding S. | Front Cardiovasc Med | 10.3389/fcvm.2021.739093 | 2021 | ||
| Gut microbiota derived indole-3-acetic acid ameliorates precancerous inflammatory intestinal milieu to inhibit tumorigenesis through IL-35. | Wang J, Hao Y, Yang Y, Zhang Y, Xu C, Yang R. | J Immunother Cancer | 10.1136/jitc-2024-011155 | 2025 | ||
| Metabolism | Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. | Wu IW, Gao SS, Chou HC, Yang HY, Chang LC, Kuo YL, Dinh MCV, Chung WH, Yang CW, Lai HC, Hsieh WP, Su SC. | Theranostics | 10.7150/thno.41725 | 2020 | |
| Microbial dysbiosis index for assessing colitis status in mouse models: A systematic review and meta-analysis. | Kim MJ, Jung DR, Lee JM, Kim I, Son H, Kim ES, Shin JH. | iScience | 10.1016/j.isci.2023.108657 | 2024 | ||
| Evaluation of Body Changes and the Anti-Obesity Effect after Consumption of Korean Fermented Food, Cheonggukjang: Randomized, Double-Blind Clinical Trial. | Han AL, Jeong SJ, Ryu MS, Yang HJ, Jeong DY, Seo YB. | Foods | 10.3390/foods12112190 | 2023 | ||
| Distinct microbial and metabolic shifts characterize acute coronary syndrome and recovery. | Xu J, Dai D, Yang Y, Gao S, Yang J, Dong C, Yang W, Yuan J, Wang T, Tian T, Yang Y, Luo F, Jiang P, Wu C, Sun X, Sui Y, Gao G, Ma W, Wu Y, Zhang J, Li J, Guo C, Cui C, Guo T, Zhao X, Yuan J, Qiao S, Hu F, Gao X, Luo X, Peng H, Wang D, Wu J, Wu C, He J, Chen WH, Yang Y, Fu J. | Imeta | 10.1002/imt2.70079 | 2025 | ||
| Phylogeny | Polyphenol-mediated microbiome modulation in STEMI patients: a pilot study | Issilbayeva A, Sergazy S, Zhashkeyev A, Gulyayev A, Kozhakhmetov S, Shulgau Z, Nurgaziyev M, Nurgaziyeva A, Zhetkenev S, Mukhanbetzhanov N, Jarmukhanov Z, Mukhanbetzhanova Z, Vinogradova E, Zhumadilov Z, Kushugulova A, Aljofan M. | Front Med (Lausanne) | 2025 | ||
| Pathogenicity | Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut. | Sutcliffe SG, Shamash M, Hynes AP, Maurice CF. | Viruses | 10.3390/v13030455 | 2021 | |
| Metabolism | Microbiota-derived tryptophan metabolism and AMPK/mTOR pathway mediate antidepressant-like effect of Shugan Hewei Decoction. | Yue Y, Ke Y, Zheng J, Wang Z, Liu H, Liu S. | Front Pharmacol | 10.3389/fphar.2024.1466336 | 2024 | |
| Pathogenicity | Nutraceutical Blends Promote Weight Loss, Inflammation Reduction, and Better Sleep: The Role of Faecalibacterium prausnitzii in Overweight Adults-A Double-Blind Trial. | Santamarina AB, Filho VN, de Freitas JA, Franco LAM, Martins RC, Fonseca JV, Orellana Turri JA, Hufnagel MT, Demarque DP, da Silva BFRB, Gusmao AF, Olivieri EHR, de Souza E, de Souza EA, Otoch JP, Pessoa AFM. | Mol Nutr Food Res | 10.1002/mnfr.202400806 | 2025 | |
| Development of an In Vitro Model of the Gut Microbiota Enriched in Mucus-Adhering Bacteria. | Calvigioni M, Panattoni A, Biagini F, Donati L, Mazzantini D, Massimino M, Daddi C, Celandroni F, Vozzi G, Ghelardi E. | Microbiol Spectr | 10.1128/spectrum.00336-23 | 2023 | ||
| Pathogenicity | Integrative metagenomic and metabolomic analyses reveal gut microbiota-derived multiple hits connected to development of gestational diabetes mellitus in humans. | Ye D, Huang J, Wu J, Xie K, Gao X, Yan K, Zhang P, Tao Y, Li Y, Zang S, Rong X, Li J, Guo J. | Gut Microbes | 10.1080/19490976.2022.2154552 | 2023 | |
| Gut Microbiota Modulates the Protective Role of Ginsenoside Compound K Against Sodium Valproate-Induced Hepatotoxicity in Rat. | Zhou L, Zeng X, Liao J, Chen L, Ouyang D. | Front Microbiol | 10.3389/fmicb.2022.936585 | 2022 | ||
| An Improved Validated Method for the Determination of Short-Chain Fatty Acids in Human Fecal Samples by Gas Chromatography with Flame Ionization Detection (GC-FID). | Smith M, Polite L, Christy A, Edirisinghe I, Burton-Freeman B, Sandhu A. | Metabolites | 10.3390/metabo13111106 | 2023 | ||
| Changes of gut microbiota reflect the severity of major depressive disorder: a cross sectional study. | Hu X, Li Y, Wu J, Zhang H, Huang Y, Tan X, Wen L, Zhou X, Xie P, Olasunkanmi OI, Zhou J, Sun Z, Liu M, Zhang G, Yang J, Zheng P, Xie P. | Transl Psychiatry | 10.1038/s41398-023-02436-z | 2023 | ||
| Aging characteristics of colorectal cancer based on gut microbiota. | Wu Y, Zhuang J, Zhang Q, Zhao X, Chen G, Han S, Hu B, Wu W, Han S. | Cancer Med | 10.1002/cam4.6414 | 2023 | ||
| Discovery of a bifunctional xylanolytic enzyme with arabinoxylan arabinofuranohydrolase-d3 and endo-xylanase activities and its application in the hydrolysis of cereal arabinoxylans. | Wang R, Zhang Y, Liu L, Yang J, Yuan H. | Microb Biotechnol | 10.1111/1751-7915.14267 | 2023 | ||
| Short-chain fatty acid-producing bacterial strains attenuate experimental ulcerative colitis by promoting M2 macrophage polarization via JAK/STAT3/FOXO3 axis inactivation. | Zhao H, Zhou Y, Xu J, Zhang Y, Wang H, Zhao C, Huang H, Yang J, Huang C, Li Y, Wang L, Nie Y. | J Transl Med | 10.1186/s12967-024-05122-w | 2024 | ||
| Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study. | Su Q, Jin C, Bo Z, Yang Y, Wang J, Wang J, Zhou J, Chen Y, Zeng H, Chen G, Wang Y. | Front Microbiol | 10.3389/fmicb.2023.1181328 | 2023 | ||
| Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis. | Liu Y, Chen Z, Li C, Sun T, Luo X, Jiang B, Liu M, Wang Q, Li T, Cao J, Li Y, Chen Y, Kuai L, Xiao F, Xu H, Cui H. | BMC Gastroenterol | 10.1186/s12876-025-03589-5 | 2025 | ||
| Genetics | Metagenomic signatures of balancing selection in the human gut. | Moeller AH. | Mol Ecol | 10.1111/mec.16474 | 2023 | |
| Pathogenicity | Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective. | Lohia S, Vlahou A, Zoidakis J. | Toxins (Basel) | 10.3390/toxins14030176 | 2022 | |
| Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes-A Systematic Review. | Voroneanu L, Burlacu A, Brinza C, Covic A, Balan GG, Nistor I, Popa C, Hogas S, Covic A. | J Clin Med | 10.3390/jcm12051948 | 2023 | ||
| Enzymology | Isolation of Bacteroides from fish and human fecal samples for identification of unique molecular markers. | Kabiri L, Alum A, Rock C, McLain JE, Abbaszadegan M. | Can J Microbiol | 10.1139/cjm-2013-0518 | 2013 | |
| A preliminary study for the clinical effect of one combinational physiotherapy and its potential influence on gut microbial composition in children with Tourette syndrome. | Bao C, Wei M, Pan H, Wen M, Liu Z, Xu Y, Jiang H. | Front Nutr | 10.3389/fnut.2023.1184311 | 2023 | ||
| Pathogenicity | The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility. | Liu X, van Beek N, Cepic A, Andreani NA, Chung CJ, Hermes BM, Yilmaz K, Benoit S, Drenovska K, Gerdes S, Glaser R, Goebeler M, Gunther C, von Georg A, Hammers CM, Holtsche MM, Hubner F, Kiritsi D, Schauer F, Linnenmann B, Huilaja L, Tasanen-Maatta K, Vassileva S, Zillikens D, Sadik CD, Schmidt E, Ibrahim S, Baines JF. | Front Immunol | 10.3389/fimmu.2023.1212551 | 2023 | |
| A microbial causal mediation analytic tool for health disparity and applications in body mass index. | Wang C, Ahn J, Tarpey T, Yi SS, Hayes RB, Li H. | Microbiome | 10.1186/s40168-023-01608-9 | 2023 | ||
| Genetics | Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography. | Yan H, Qin Q, Chen J, Yan S, Li T, Gao X, Yang Y, Li A, Ding S. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.823262 | 2021 | |
| Effects of the Brown Seaweed Laminaria japonica Supplementation on Serum Concentrations of IgG, Triglycerides, and Cholesterol, and Intestinal Microbiota Composition in Rats. | Kim JY, Kwon YM, Kim IS, Kim JA, Yu DY, Adhikari B, Lee SS, Choi IS, Cho KK. | Front Nutr | 10.3389/fnut.2018.00023 | 2018 | ||
| Metabolism | The dynamics of the gut microbiota in prediabetes during a four-year follow-up among European patients-an IMI-DIRECT prospective study. | Lyu L, Fan Y, Vogt JK, Clos-Garcia M, Bonnefond A, Pedersen HK, Dutta A, Koivula R, Sharma S, Allin KH, Brorsson C, Cederberg H, Chabanova E, De Masi F, Dermitzakis E, Elders PJ, Blom MT, Hollander M, Eriksen R, Forgie I, Frost G, Giordano GN, Grallert H, Haid M, Hansen TH, Jablonka B, Kokkola T, Mahajan A, Mari A, McDonald TJ, Musholt PB, Pavo I, Prehn C, Ridderstrale M, Ruetten H, Hart LM', Schwenk JM, Stankevic E, Thomsen HS, Vangipurapu J, Vestergaard H, Vinuela A, Walker M, Hansen T, Linneberg A, Nielsen HB, Brunak S, McCarthy MI, Froguel P, Adamski J, Franks PW, Laakso M, Beulens JWJ, Pearson E, Pedersen O. | Genome Med | 10.1186/s13073-025-01508-7 | 2025 | |
| Enzymology | Techniques for RNA extraction from cells cultured in starPEG-heparin hydrogels. | Jaeschke A, Harvey NR, Tsurkan M, Werner C, Griffiths LR, Haupt LM, Bray LJ. | Open Biol | 10.1098/rsob.200388 | 2021 | |
| Metabolism | Colonic microflora and plasma metabolite-based comparative analysis of unilateral ureteral obstruction-induced chronic kidney disease after treatment with the Chinese medicine FuZhengHuaYuJiangZhuTongLuo and AST-120. | Chen Z, Wu S, Huang L, Li J, Li X, Zeng Y, Chen Z, Chen M. | Heliyon | 10.1016/j.heliyon.2024.e24987 | 2024 | |
| Genetics | Duck gut metagenome reveals the microbiome signatures linked to intestinal regional, temporal development, and rearing condition. | Ma L, Lyu W, Zeng T, Wang W, Chen Q, Zhao J, Zhang G, Lu L, Yang H, Xiao Y. | Imeta | 10.1002/imt2.198 | 2024 | |
| Alterations of the intestinal microbiota in age-related macular degeneration. | Zhang Y, Wang T, Wan Z, Bai J, Xue Y, Dai R, Wang M, Peng Q. | Front Microbiol | 10.3389/fmicb.2023.1069325 | 2023 | ||
| Metabolism | Gut Microbiota Alterations and Their Functional Differences in Depression According to Enterotypes in Asian Individuals. | Park S, Li C, Wu X, Zhang T. | Int J Mol Sci | 10.3390/ijms241713329 | 2023 | |
| Genetics | Alterations of gut viral signals in atrial fibrillation: complex linkage with gut bacteriome. | Zuo K, Li J, Fang C, Zhong J, Xu L, Yang X. | Aging (Albany NY) | 10.18632/aging.204222 | 2022 | |
| Checkpoint inhibitor responses can be regulated by the gut microbiota - A systematic review. | Zeriouh M, Raskov H, Kvich L, Gogenur I, Bennedsen ALB. | Neoplasia | 10.1016/j.neo.2023.100923 | 2023 | ||
| Consistent signatures in the human gut microbiome of longevous populations. | Chen S, Zhang Z, Liu S, Chen T, Lu Z, Zhao W, Mou X, Liu S. | Gut Microbes | 10.1080/19490976.2024.2393756 | 2024 | ||
| Metabolism | Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. | Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L, Calder AG, Anderson SE, Flint HJ. | Mol Nutr Food Res | 10.1002/mnfr.201200594 | 2013 | |
| The Nursing Home Older Adult Gut Microbiome Composition Shows Time-dependent Dysbiosis and Is Influenced by Medication Exposures, Age, Environment, and Frailty. | Haran JP, Zeamer A, Ward DV, Dutta P, Bucci V, McCormick BA. | J Gerontol A Biol Sci Med Sci | 10.1093/gerona/glab167 | 2021 | ||
| Anti-Obesity Effects of Traditional and Commercial Kochujang in Overweight and Obese Adults: A Randomized Controlled Trial. | Han AL, Jeong SJ, Ryu MS, Yang HJ, Jeong DY, Park DS, Lee HK. | Nutrients | 10.3390/nu14142783 | 2022 | ||
| Childhood Obesity and the Cryptic Language of the Microbiota: Metabolomics' Upgrading. | Bosco A, Loi M, Pinna G, Pintus R, Fanos V, Dessi A. | Metabolites | 10.3390/metabo13030414 | 2023 | ||
| Phylogeny | Characterization of the gut microbiota in Chinese children with overweight and obesity using 16S rRNA gene sequencing. | Chen X, Zhang D, Sun H, Jiang F, Shen Y, Wei P, Shen X. | PeerJ | 10.7717/peerj.11439 | 2021 | |
| A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients. | Obuya S, Elkholy A, Avuthu N, Behring M, Bajpai P, Agarwal S, Kim HG, El-Nikhely N, Akinyi P, Orwa J, Afaq F, Abdalla M, Michael A, Farouk M, Bateman LB, Fouad M, Saleh M, Guda C, Manne U, Arafat W. | J Gastrointest Oncol | 10.21037/jgo-22-116 | 2022 | ||
| Microbial richness and air chemistry in aerosols above the PBL confirm 2,000-km long-distance transport of potential human pathogens. | Rodo X, Pozdniakova S, Borras S, Matsuki A, Tanimoto H, Armengol MP, Pey I, Vila J, Munoz L, Santamaria S, Canas L, Morgui JA, Fontal A, Curcoll R. | Proc Natl Acad Sci U S A | 10.1073/pnas.2404191121 | 2024 | ||
| Altered Fecal Microbiome and Metabolome in a Mouse Model of Choroidal Neovascularization. | Li Y, Cai Y, Huang Q, Tan W, Li B, Zhou H, Wang Z, Zou J, Ding C, Jiang B, Yoshida S, Zhou Y. | Front Microbiol | 10.3389/fmicb.2021.738796 | 2021 | ||
| Database limitations for studying the human gut microbiome. | Dias CK, Starke R, Pylro VS, Morais DK. | PeerJ Comput Sci | 10.7717/peerj-cs.289 | 2020 | ||
| Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome. | Jiang H, Zhao X, Zang M, Fu R, Shao Z, Liu C. | Oxid Med Cell Longev | 10.1155/2022/1482811 | 2022 | ||
| Pathogenicity | Oleuropein Ameliorates Advanced Stage of Type 2 Diabetes in db/db Mice by Regulating Gut Microbiota. | Zheng S, Wang Y, Fang J, Geng R, Li M, Zhao Y, Kang SG, Huang K, Tong T. | Nutrients | 10.3390/nu13072131 | 2021 | |
| Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration. | Zinkernagel MS, Zysset-Burri DC, Keller I, Berger LE, Leichtle AB, Largiader CR, Fiedler GM, Wolf S. | Sci Rep | 10.1038/srep40826 | 2017 | ||
| Gene variations in autism spectrum disorder are associated with alteration of gut microbiota, metabolites and cytokines. | Liu Z, Mao X, Dan Z, Pei Y, Xu R, Guo M, Liu K, Zhang F, Chen J, Su C, Zhuang Y, Tang J, Xia Y, Qin L, Hu Z, Liu X. | Gut Microbes | 10.1080/19490976.2020.1854967 | 2021 | ||
| Phylogeny | Screening of Human Gut Bacterial Culture Collection Identifies Species That Biotransform Quercetin into Metabolites with Anticancer Properties. | Sankaranarayanan R, Sekhon PK, Ambat A, Nelson J, Jose D, Bhat GJ, Scaria J. | Int J Mol Sci | 10.3390/ijms22137045 | 2021 | |
| Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin. | Yang J, Rui W, Zhong S, Li X, Liu W, Meng L, Li Y, Huang H. | Gut Microbes | 10.1080/19490976.2024.2390133 | 2024 | ||
| Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. | Golcic M, Jones RL, Huang P, Napolitano A. | Cancers (Basel) | 10.3390/cancers15164081 | 2023 | ||
| Phylogeny | Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples. | Tong J, Liu C, Summanen P, Xu H, Finegold SM. | Anaerobe | 10.1016/j.anaerobe.2011.03.004 | 2011 | |
| Celiac disease gut microbiome studies in the third millennium: reviewing the findings and gaps of available literature. | Luz VCC, Pereira SG. | Front Med Technol | 10.3389/fmedt.2024.1413637 | 2024 | ||
| Treadmill exercise has minimal impact on obesogenic diet-related gut microbiome changes but alters adipose and hypothalamic gene expression in rats. | Leigh SJ, Kaakoush NO, Escorihuela RM, Westbrook RF, Morris MJ. | Nutr Metab (Lond) | 10.1186/s12986-020-00492-6 | 2020 | ||
| Compliance with Nutritional Recommendations and Gut Microbiota Profile in Galician Overweight/Obese and Normal-Weight Individuals. | Sinisterra-Loaiza L, Alonso-Lovera P, Cardelle-Cobas A, Miranda JM, Vazquez BI, Cepeda A. | Nutrients | 10.3390/nu15153418 | 2023 | ||
| Comparative analysis of Parkinson's and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion. | Krueger ME, Boles JS, Simon ZD, Alvarez SD, McFarland NR, Okun MS, Zimmermann EM, Forsmark CE, Tansey MG. | NPJ Parkinsons Dis | 10.1038/s41531-025-00894-4 | 2025 | ||
| Impacts of dietary exposure to pesticides on faecal microbiome metabolism in adult twins. | Mesnage R, Bowyer RCE, El Balkhi S, Saint-Marcoux F, Gardere A, Ducarmon QR, Geelen AR, Zwittink RD, Tsoukalas D, Sarandi E, Paramera EI, Spector T, Steves CJ, Antoniou MN. | Environ Health | 10.1186/s12940-022-00860-0 | 2022 | ||
| Metabolism | Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. | Wu IW, Lin CY, Chang LC, Lee CC, Chiu CY, Hsu HJ, Sun CY, Chen YC, Kuo YL, Yang CW, Gao SS, Hsieh WP, Chung WH, Lai HC, Su SC. | Int J Biol Sci | 10.7150/ijbs.37421 | 2020 | |
| Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency. | Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, Rengassamy J, Alfaro A, Bied M, Fidelle M, Ferrere G, Daillere R, Arbab A, Amine-Hneineh R, Pages A, Dartigues P, Ly P, Simon S, Durand S, Gottschlich A, Ginhoux F, Bleriot C, Liu P, Zhao L, Creusot L, Rolhion N, Derosa L, Kroemer G, Menger L, Kobold S, Castilla-Llorente C, Sokol H, Casola S, Pasolli E, Zitvogel L, Bigenwald C. | Cancer Discov | 10.1158/2159-8290.cd-24-1230 | 2025 | ||
| Pathogenicity | Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward. | Habibi S, Rashidi A. | Gut Microbes | 10.1080/19490976.2023.2229567 | 2023 | |
| Characterization of the bacterial fecal microbiota composition of pigs preceding the clinical signs of swine dysentery. | Barbosa JA, Aguirre JCP, Nosach R, Harding JCS, Cantarelli VS, Costa MO. | PLoS One | 10.1371/journal.pone.0294273 | 2023 | ||
| Metabolism | Propionate-producing bacteria in the intestine may associate with skewed responses of IL10-producing regulatory T cells in patients with relapsing polychondritis. | Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, Murayama MA, Ueda Y, Wakisaka S, Suzuki T, Suzuki N. | PLoS One | 10.1371/journal.pone.0203657 | 2018 | |
| The synergistic effects of polyphenols and intestinal microbiota on osteoporosis. | Wang K, Hu S. | Front Immunol | 10.3389/fimmu.2023.1285621 | 2023 | ||
| Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis. | Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, Zhang H, Zhang Z, He J, Cui B, Zhang X, Wu Z, Dong M, Cheng W, Tao S, Wei H. | Front Immunol | 10.3389/fimmu.2022.836542 | 2022 | ||
| Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review. | Larsen PP, Dinet V, Delcourt C, Helmer C, Linard M. | Ophthalmol Sci | 10.1016/j.xops.2024.100668 | 2025 | ||
| Genetics | Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage. | Zhang J, Zhao J, Jin H, Lv R, Shi H, De G, Yang B, Sun Z, Zhang H. | Gut Microbes | 10.1080/19490976.2020.1722054 | 2020 | |
| Plasma and urine proteomics and gut microbiota analysis reveal potential factors affecting COVID-19 vaccination response. | Hu C, Hu W, Tang B, Bao Q, Jiang X, Tang L, Wang H, He L, Lv M, Xiao Y, Liu C, Li X, Liu Y, Li J, Huang G, Dong Z, Li Z, Guo T, Yang S. | iScience | 10.1016/j.isci.2024.108851 | 2024 | ||
| Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis. | Sharpton SR, Podlaha O, Chuang JC, Gindin Y, Myers RP, Loomba R. | Therap Adv Gastroenterol | 10.1177/17562848221098243 | 2022 | ||
| Pathogenicity | Gut Microbiota Alteration Is Associated With Cognitive Deficits in Genetically Diabetic (Db/db) Mice During Aging. | Zhang J, Zhang Y, Yuan Y, Liu L, Zhao Y, Wang X. | Front Aging Neurosci | 10.3389/fnagi.2021.815562 | 2021 | |
| Genetics | Association of distinct microbial signatures with premalignant colorectal adenomas. | Lee JWJ, Plichta DR, Asher S, Delsignore M, Jeong T, McGoldrick J, Staller K, Khalili H, Xavier RJ, Chung DC. | Cell Host Microbe | 10.1016/j.chom.2023.04.007 | 2023 | |
| Extracellular vesicles from mesenchymal stem cells alter gut microbiota and improve neuroinflammation and motor impairment in rats with mild liver damage. | Mincheva G, Felipo V, Moreno-Manzano V, Benitez-Paez A, Llansola M. | Neurotherapeutics | 10.1016/j.neurot.2024.e00445 | 2024 | ||
| Immunological design of commensal communities to treat intestinal infection and inflammation. | Brown RL, Larkinson MLY, Clarke TB. | PLoS Pathog | 10.1371/journal.ppat.1009191 | 2021 | ||
| Metabolism | A highly active heparinase I from Bacteroides cellulosilyticus: Cloning, high level expression, and molecular characterization. | Gao LW, Zhu HT, Liu CY, Lv ZX, Fan XM, Zhang YW. | PLoS One | 10.1371/journal.pone.0240920 | 2020 | |
| Pathogenicity | Engraftment of aging-related human gut microbiota and the effect of a seven-species consortium in a pre-clinical model. | Ye H, Ghosh TS, Hueston CM, Vlckova K, Golubeva AV, Hyland NP, O'Toole PW. | Gut Microbes | 10.1080/19490976.2023.2282796 | 2023 | |
| A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer. | Villani A, Fontana A, Panebianco C, Ferro C, Copetti M, Pavlovic R, Drago D, Fiorentini C, Terracciano F, Bazzocchi F, Canistro G, Pisati F, Maiello E, Latiano TP, Perri F, Pazienza V. | Gut Microbes | 10.1080/19490976.2024.2375483 | 2024 | ||
| Gut microbiota in regulatory T cell generation and function: mechanisms and health implications. | Sharma A, Sharma G, Im SH. | Gut Microbes | 10.1080/19490976.2025.2516702 | 2025 | ||
| Comprehensive Analysis Reveals Novel Interactions between Circulating MicroRNAs and Gut Microbiota Composition in Human Obesity. | Assmann TS, Cuevas-Sierra A, Riezu-Boj JI, Milagro FI, Martinez JA. | Int J Mol Sci | 10.3390/ijms21249509 | 2020 | ||
| Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis. | Ji C, Lu F, Wu Y, Lu Z, Mo Y, Han L, Lin Q, Liu X, Zou C. | Biomed Res Int | 10.1155/2022/1896781 | 2022 | ||
| Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients. | Picchianti Diamanti A, Panebianco C, Salerno G, Di Rosa R, Salemi S, Sorgi ML, Meneguzzi G, Mariani MB, Rai A, Iacono D, Sesti G, Pazienza V, Lagana B. | Microorganisms | 10.3390/microorganisms8121989 | 2020 | ||
| Metabolism | Multi-omic Profiling Reveals that Intra-abdominal-Hypertension-Induced Intestinal Damage Can Be Prevented by Microbiome and Metabolic Modulations with 5-Hydroxyindoleacetic Acid as a Diagnostic Marker. | Li F, Jiang L, Pan S, Jiang S, Fan Y, Jiang C, Gao C, Leng Y. | mSystems | 10.1128/msystems.01204-21 | 2022 | |
| Multi-Omics Analysis Demonstrates the Critical Role of Non-Ethanolic Components of Alcoholic Beverages in the Host Microbiome and Metabolome: A Human- and Animal-Based Study. | Sarkar P, Kandimalla R, Bhattacharya A, Wahengbam R, Dehingia M, Kalita MC, Talukdar NC, Talukdar R, Khan MR. | Microorganisms | 10.3390/microorganisms11061501 | 2023 | ||
| Genetics | Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy. | Zhang L, Wang Z, Zhang X, Zhao L, Chu J, Li H, Sun W, Yang C, Wang H, Dai W, Yan S, Chen X, Xu D. | Microbiol Spectr | 10.1128/spectrum.00324-22 | 2022 | |
| Safety and Modulatory Effects of Humanized Galacto-Oligosaccharides on the Gut Microbiome. | Arnold JW, Whittington HD, Dagher SF, Roach J, Azcarate-Peril MA, Bruno-Barcena JM. | Front Nutr | 10.3389/fnut.2021.640100 | 2021 | ||
| Goat Milk Consumption Enhances Innate and Adaptive Immunities and Alleviates Allergen-Induced Airway Inflammation in Offspring Mice. | Kao HF, Wang YC, Tseng HY, Wu LS, Tsai HJ, Hsieh MH, Chen PC, Kuo WS, Liu LF, Liu ZG, Wang JY. | Front Immunol | 10.3389/fimmu.2020.00184 | 2020 | ||
| Bacteriophage-Mediated Perturbation of Defined Bacterial Communities in an In Vitro Model of the Human Gut. | Attai H, Wilde J, Liu R, Chopyk J, Garcia AG, Allen-Vercoe E, Pride D. | Microbiol Spectr | 10.1128/spectrum.01135-22 | 2022 | ||
| Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis. | Strauss JC, Haskey N, Ramay HR, Ghosh TS, Taylor LM, Yousuf M, Ohland C, McCoy KD, Ingram RJM, Ghosh S, Panaccione R, Raman M. | Int J Mol Sci | 10.3390/ijms24087323 | 2023 | ||
| Pathogenicity | Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). | Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL. | Clin Infect Dis | 10.1086/647940 | 2010 | |
| Pathogenicity | Microbiome as an endocrine organ and its relationship with eye diseases: Effective factors and new targeted approaches. | Haghshenas L, Banihashemi S, Malekzadegan Y, Catanzaro R, Moghadam Ahmadi A, Marotta F. | World J Gastrointest Pathophysiol | 10.4291/wjgp.v15.i5.96446 | 2024 | |
| Genetics | Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism. | Huang Y, Xu W, Dong W, Chen G, Sun Y, Zeng X. | J Adv Res | 10.1016/j.jare.2024.06.027 | 2025 | |
| Phylogeny | Gut Microbial Characteristics of Adult Patients With Epilepsy. | Dong L, Zheng Q, Cheng Y, Zhou M, Wang M, Xu J, Xu Z, Wu G, Yu Y, Ye L, Feng Z. | Front Neurosci | 10.3389/fnins.2022.803538 | 2022 | |
| Gut microbiota modify risk for dietary glycemia-induced age-related macular degeneration. | Rowan S, Taylor A. | Gut Microbes | 10.1080/19490976.2018.1435247 | 2018 | ||
| Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial. | Zhang X, Ren H, Zhao C, Shi Z, Qiu L, Yang F, Zhou X, Han X, Wu K, Zhong H, Li Y, Li J, Ji L. | Diabetologia | 10.1007/s00125-022-05768-5 | 2022 | ||
| Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study). | Di Iorio BR, Rocchetti MT, De Angelis M, Cosola C, Marzocco S, Di Micco L, di Bari I, Accetturo M, Vacca M, Gobbetti M, Di Iorio M, Bellasi A, Gesualdo L. | J Clin Med | 10.3390/jcm8091424 | 2019 | ||
| Metabolism | IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM. | Catanzaro JR, Strauss JD, Bielecka A, Porto AF, Lobo FM, Urban A, Schofield WB, Palm NW. | Sci Rep | 10.1038/s41598-019-49923-2 | 2019 | |
| Oral and gut dysbiosis leads to functional alterations in Parkinson's disease. | Jo S, Kang W, Hwang YS, Lee SH, Park KW, Kim MS, Lee H, Yoon HJ, Park YK, Chalita M, Lee JH, Sung H, Lee JY, Bae JW, Chung SJ. | NPJ Parkinsons Dis | 10.1038/s41531-022-00351-6 | 2022 | ||
| Phylogeny | Dissection of the gut microbiota in mothers and children with chronic Trichuris trichiura infection in Pemba Island, Tanzania. | Chen H, Mozzicafreddo M, Pierella E, Carletti V, Piersanti A, Ali SM, Ame SM, Wang C, Miceli C. | Parasit Vectors | 10.1186/s13071-021-04580-1 | 2021 | |
| Phylogeny | Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients. | Mori G, Orena BS, Cultrera I, Barbieri G, Albertini AM, Ranzani GN, Carnevali I, Tibiletti MG, Pasca MR. | Front Microbiol | 10.3389/fmicb.2019.01746 | 2019 | |
| Comparative Study of Salivary, Duodenal, and Fecal Microbiota Composition Across Adult Celiac Disease. | Panelli S, Capelli E, Lupo GFD, Schiepatti A, Betti E, Sauta E, Marini S, Bellazzi R, Vanoli A, Pasi A, Cacciatore R, Bacchi S, Balestra B, Pastoris O, Frulloni L, Corazza GR, Biagi F, Ciccocioppo R. | J Clin Med | 10.3390/jcm9041109 | 2020 | ||
| RWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction. | Niu YW, Qu CQ, Wang GH, Yan GY. | Front Microbiol | 10.3389/fmicb.2019.01578 | 2019 | ||
| Cell-Free Supernatant of Odoribacter splanchnicus Isolated From Human Feces Exhibits Anti-colorectal Cancer Activity. | Oh BS, Choi WJ, Kim JS, Ryu SW, Yu SY, Lee JS, Park SH, Kang SW, Lee J, Jung WY, Kim YM, Jeong JH, Lee JH. | Front Microbiol | 10.3389/fmicb.2021.736343 | 2021 | ||
| Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients. | Medina DA, Pedreros JP, Turiel D, Quezada N, Pimentel F, Escalona A, Garrido D. | PeerJ | 10.7717/peerj.3443 | 2017 | ||
| Pathogenicity | Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes. | Silamikele L, Silamikelis I, Ustinova M, Kalnina Z, Elbere I, Petrovska R, Kalnina I, Klovins J. | Front Endocrinol (Lausanne) | 10.3389/fendo.2021.626359 | 2021 | |
| Pathogenicity | Altered Gut Microbial Profile Accompanied by Abnormal Fatty Acid Metabolism Activity Exacerbates Endometrial Cancer Progression. | Zhao SS, Chen L, Yang J, Wu ZH, Wang XY, Zhang Q, Liu WJ, Liu HX. | Microbiol Spectr | 10.1128/spectrum.02612-22 | 2022 | |
| A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. | Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert ML, Mor U, Fante MA, Schmidt S, Hayase E, Hayase T, Rohrbach R, Chang CC, McDaniel L, Flores I, Gaiser R, Edinger M, Wolff D, Heidenreich M, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Steiner RE, Jain P, Nastoupil LJ, Westin J, Arora R, Wang ML, Turner J, Menges M, Hidalgo-Vargas M, Reid K, Dreger P, Schmitt A, Muller-Tidow C, Locke FL, Davila ML, Champlin RE, Flowers CR, Shpall EJ, Poeck H, Neelapu SS, Schmitt M, Subklewe M, Jain MD, Jenq RR, Elinav E. | Nat Med | 10.1038/s41591-023-02234-6 | 2023 | ||
| Genetics | Successful Fecal Microbiota Transplantation in a Patient Suffering From Irritable Bowel Syndrome and Recurrent Urinary Tract Infections. | Hocquart M, Pham T, Kuete E, Tomei E, Lagier JC, Raoult D. | Open Forum Infect Dis | 10.1093/ofid/ofz398 | 2019 | |
| Serum trimethylamine-N-oxide and gut microbiome alterations are associated with cholesterol deposition in the liver of laying hens fed with rapeseed meal. | Zhu L, Wang J, Ding X, Bai S, Zeng Q, Xuan Y, Fraley GS, Zhang K. | Anim Nutr | 10.1016/j.aninu.2021.02.008 | 2021 | ||
| Differences in the oral and intestinal microbiotas in pregnant women varying in periodontitis and gestational diabetes mellitus conditions. | Zhang X, Wang P, Ma L, Guo R, Zhang Y, Wang P, Zhao J, Liu J. | J Oral Microbiol | 10.1080/20002297.2021.1883382 | 2021 | ||
| Pathogenicity | Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria. | Seelbinder B, Chen J, Brunke S, Vazquez-Uribe R, Santhaman R, Meyer AC, de Oliveira Lino FS, Chan KF, Loos D, Imamovic L, Tsang CC, Lam RP, Sridhar S, Kang K, Hube B, Woo PC, Sommer MOA, Panagiotou G. | Microbiome | 10.1186/s40168-020-00899-6 | 2020 | |
| Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice. | Dziarski R, Park SY, Kashyap DR, Dowd SE, Gupta D. | PLoS One | 10.1371/journal.pone.0146162 | 2016 | ||
| Metabolism | Bacteroides thetaiotaomicron uses a widespread extracellular DNase to promote bile-dependent biofilm formation. | Bechon N, Mihajlovic J, Lopes AA, Vendrell-Fernandez S, Deschamps J, Briandet R, Sismeiro O, Martin-Verstraete I, Dupuy B, Ghigo JM. | Proc Natl Acad Sci U S A | 10.1073/pnas.2111228119 | 2022 | |
| Pathogenicity | Tipping the Balance: Vitamin D Inadequacy in Children Impacts the Major Gut Bacterial Phyla. | Singh P, Rawat A, Saadaoui M, Elhag D, Tomei S, Elanbari M, Akobeng AK, Mustafa A, Abdelgadir I, Udassi S, Hendaus MA, Al Khodor S. | Biomedicines | 10.3390/biomedicines10020278 | 2022 | |
| Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. | Sun Z, Song ZG, Liu C, Tan S, Lin S, Zhu J, Dai FH, Gao J, She JL, Mei Z, Lou T, Zheng JJ, Liu Y, He J, Zheng Y, Ding C, Qian F, Zheng Y, Chen YM. | BMC Med | 10.1186/s12916-021-02212-0 | 2022 | ||
| Genetics | Microbial strain-level population structure and genetic diversity from metagenomes. | Truong DT, Tett A, Pasolli E, Huttenhower C, Segata N. | Genome Res | 10.1101/gr.216242.116 | 2017 | |
| Effects of enriched seafood sticks (heat-inactivated B. animalis subsp. lactis CECT 8145, inulin, omega-3) on cardiometabolic risk factors and gut microbiota in abdominally obese subjects: randomized controlled trial. | Companys J, Calderon-Perez L, Pla-Paga L, Llaurado E, Sandoval-Ramirez BA, Gosalbes MJ, Arregui A, Barandiaran M, Caimari A, Del Bas JM, Arola L, Valls RM, Sola R, Pedret A. | Eur J Nutr | 10.1007/s00394-022-02904-0 | 2022 | ||
| Pathogenicity | Effect of host breeds on gut microbiome and serum metabolome in meat rabbits. | Ye X, Zhou L, Zhang Y, Xue S, Gan QF, Fang S. | BMC Vet Res | 10.1186/s12917-020-02732-6 | 2021 | |
| Limosilactobacillus mucosae-derived extracellular vesicles modulates macrophage phenotype and orchestrates gut homeostasis in a diarrheal piglet model. | Li J, Feng S, Wang Z, He J, Zhang Z, Zou H, Wu Z, Liu X, Wei H, Tao S. | NPJ Biofilms Microbiomes | 10.1038/s41522-023-00403-6 | 2023 | ||
| Pathogenicity | The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals. | Singh P, Rawat A, Alwakeel M, Sharif E, Al Khodor S. | Sci Rep | 10.1038/s41598-020-77806-4 | 2020 | |
| Identification and Analysis of Human Microbe-Disease Associations by Matrix Decomposition and Label Propagation. | Qu J, Zhao Y, Yin J. | Front Microbiol | 10.3389/fmicb.2019.00291 | 2019 | ||
| FiberGrowth Pipeline: A Framework Toward Predicting Fiber-Specific Growth From Human Gut Bacteroidetes Genomes. | Colnet B, Sieber CMK, Perraudeau F, Leclerc M. | Front Microbiol | 10.3389/fmicb.2021.632567 | 2021 | ||
| Phylogeny | Gut Microbiota Composition Associated With Clostridium difficile-Positive Diarrhea and C. difficile Type in ICU Patients. | Duan J, Meng X, Liu S, Zhou P, Zeng C, Fu C, Dou Q, Wu A, Li C. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00190 | 2020 | |
| Pathogenicity | The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic. | Lv L, Jiang H, Chen X, Wang Q, Wang K, Ye J, Li Y, Fang D, Lu Y, Yang L, Gu S, Chen J, Diao H, Yan R, Li L. | Front Immunol | 10.3389/fimmu.2021.713647 | 2021 | |
| High prevalence of cfxA beta-lactamase in aminopenicillin-resistant Prevotella strains isolated from periodontal pockets. | Fosse T, Madinier I, Hannoun L, Giraud-Morin C, Hitzig C, Charbit Y, Ourang S. | Oral Microbiol Immunol | 10.1046/j.0902-0055.2001.00096.x | 2002 | ||
| Metabolism | A comprehensive analysis of the faecal microbiome and metabolome of Strongyloides stercoralis infected volunteers from a non-endemic area. | Jenkins TP, Formenti F, Castro C, Piubelli C, Perandin F, Buonfrate D, Otranto D, Griffin JL, Krause L, Bisoffi Z, Cantacessi C. | Sci Rep | 10.1038/s41598-018-33937-3 | 2018 | |
| Metabolism | Degradation of complex arabinoxylans by human colonic Bacteroidetes. | Pereira GV, Abdel-Hamid AM, Dutta S, D'Alessandro-Gabazza CN, Wefers D, Farris JA, Bajaj S, Wawrzak Z, Atomi H, Mackie RI, Gabazza EC, Shukla D, Koropatkin NM, Cann I. | Nat Commun | 10.1038/s41467-020-20737-5 | 2021 | |
| Identification of Protein Recognition Elements within Heparin Chains Using Enzymatic Foot-Printing in Solution and Online SEC/MS. | Niu C, Zhao Y, Bobst CE, Savinov SN, Kaltashov IA. | Anal Chem | 10.1021/acs.analchem.0c00115 | 2020 | ||
| Heparinase Digestion of 3-O-Sulfated Sequences: Selective Heparinase II Digestion for Separation and Identification of Binding Sequences Present in ATIII Affinity Fractions of Bovine Intestinal Heparins. | Mourier P. | Front Med (Lausanne) | 10.3389/fmed.2022.841726 | 2022 | ||
| Transcriptome | Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer. | Wang Q, Ye J, Fang D, Lv L, Wu W, Shi D, Li Y, Yang L, Bian X, Wu J, Jiang X, Wang K, Wang Q, Hodson MP, Thibaut LM, Ho JWK, Giannoulatou E, Li L. | BMC Microbiol | 10.1186/s12866-020-01762-2 | 2020 | |
| Enzymology | Polysaccharide utilization loci-driven enzyme discovery reveals BD-FAE: a bifunctional feruloyl and acetyl xylan esterase active on complex natural xylans. | Hameleers L, Penttinen L, Ikonen M, Jaillot L, Faure R, Terrapon N, Deuss PJ, Hakulinen N, Master ER, Jurak E. | Biotechnol Biofuels | 10.1186/s13068-021-01976-0 | 2021 | |
| Pathogenicity | Microbiome therapeutics for hepatic encephalopathy. | Bloom PP, Tapper EB, Young VB, Lok AS. | J Hepatol | 10.1016/j.jhep.2021.08.004 | 2021 | |
| Bacteroides uniformis and its preferred substrate, alpha-cyclodextrin, enhance endurance exercise performance in mice and human males. | Morita H, Kano C, Ishii C, Kagata N, Ishikawa T, Hirayama A, Uchiyama Y, Hara S, Nakamura T, Fukuda S. | Sci Adv | 10.1126/sciadv.add2120 | 2023 | ||
| Enzymology | Improved production of 2'-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative alpha-1, 2-fucosyltransferase from Bacillus cereus. | Xu M, Meng X, Zhang W, Shen Y, Liu W. | Microb Cell Fact | 10.1186/s12934-021-01657-5 | 2021 | |
| Pathogenicity | Tibet plateau probiotic mitigates chromate toxicity in mice by alleviating oxidative stress in gut microbiota. | Feng P, Ye Z, Han H, Ling Z, Zhou T, Zhao S, Virk AK, Kakade A, Abomohra AE, El-Dalatony MM, Salama ES, Liu P, Li X. | Commun Biol | 10.1038/s42003-020-0968-3 | 2020 | |
| Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant. | Liu R, Kang JD, Sartor RB, Sikaroodi M, Fagan A, Gavis EA, Zhou H, Hylemon PB, Herzog JW, Li X, Lippman RH, Gonzalez-Maeso J, Wade JB, Ghosh S, Gurley E, Gillevet PM, Bajaj JS. | Hepatology | 10.1002/hep.30827 | 2020 | ||
| Structure of the fimbrial protein Mfa4 from Porphyromonas gingivalis in its precursor form: implications for a donor-strand complementation mechanism. | Kloppsteck P, Hall M, Hasegawa Y, Persson K. | Sci Rep | 10.1038/srep22945 | 2016 | ||
| The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status. | Stojic J, Kukla M, Grgurevic I. | Diagnostics (Basel) | 10.3390/diagnostics13182960 | 2023 | ||
| Enzymology | Microbiology of the infected recurrent sacrococcygeal pilonidal sinus. | Ardelt M, Dittmar Y, Kocijan R, Rodel J, Schulz B, Scheuerlein H, Settmacher U. | Int Wound J | 10.1111/iwj.12274 | 2016 | |
| Metabolism | Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model. | Ma S, Yeom J, Lim YH. | Sci Rep | 10.1038/s41598-020-62497-8 | 2020 | |
| MALDI-TOF MS versus VITEK 2 ANC card for identification of anaerobic bacteria. | Li Y, Gu B, Liu G, Xia W, Fan K, Mei Y, Huang P, Pan S. | J Thorac Dis | 10.3978/j.issn.2072-1439.2014.02.15 | 2014 | ||
| Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients. | Zeybel M, Altay O, Arif M, Li X, Yang H, Fredolini C, Akyildiz M, Saglam B, Gonenli MG, Ural D, Kim W, Schwenk JM, Zhang C, Shoaie S, Nielsen J, Uhlen M, Boren J, Mardinoglu A. | Mol Syst Biol | 10.15252/msb.202110459 | 2021 | ||
| Pathogenicity | In vitro interactions of Alternaria mycotoxins, an emerging class of food contaminants, with the gut microbiota: a bidirectional relationship. | Crudo F, Aichinger G, Mihajlovic J, Varga E, Dellafiora L, Warth B, Dall'Asta C, Berry D, Marko D. | Arch Toxicol | 10.1007/s00204-021-03043-x | 2021 | |
| Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India. | Gupta A, Dhakan DB, Maji A, Saxena R, P K VP, Mahajan S, Pulikkan J, Kurian J, Gomez AM, Scaria J, Amato KR, Sharma AK, Sharma VK. | mSystems | 10.1128/msystems.00438-19 | 2019 | ||
| Metabolism | The 3-O-sulfation of heparan sulfate modulates protein binding and lyase degradation. | Chopra P, Joshi A, Wu J, Lu W, Yadavalli T, Wolfert MA, Shukla D, Zaia J, Boons GJ. | Proc Natl Acad Sci U S A | 10.1073/pnas.2012935118 | 2021 | |
| Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. | Polster SP, Sharma A, Tanes C, Tang AT, Mericko P, Cao Y, Carrion-Penagos J, Girard R, Koskimaki J, Zhang D, Stadnik A, Romanos SG, Lyne SB, Shenkar R, Yan K, Lee C, Akers A, Morrison L, Robinson M, Zafar A, Bittinger K, Kim H, Gilbert JA, Kahn ML, Shen L, Awad IA. | Nat Commun | 10.1038/s41467-020-16436-w | 2020 | ||
| Pathogenicity | Probiotic-directed modulation of gut microbiota is basal microbiome dependent. | Hou Q, Zhao F, Liu W, Lv R, Khine WWT, Han J, Sun Z, Lee YK, Zhang H. | Gut Microbes | 10.1080/19490976.2020.1736974 | 2020 | |
| Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. | de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, Hanssen N, Attaye I, Bakker G, Duinkerken G, Joosten A, Prodan A, Levin E, Levels H, Potter van Loon B, van Bon A, Brouwer C, van Dam S, Simsek S, van Raalte D, Stam F, Gerdes V, Hoogma R, Diekman M, Gerding M, Rustemeijer C, de Bakker B, Hoekstra J, Zwinderman A, Bergman J, Holleman F, Piemonti L, De Vos W, Roep B, Nieuwdorp M. | Gut | 10.1136/gutjnl-2020-322630 | 2021 | ||
| Enzymology | Genetic transformation of Porphyromonas gingivalis by electroporation. | Yoshimoto H, Takahashi Y, Hamada N, Umemoto T. | Oral Microbiol Immunol | 10.1111/j.1399-302x.1993.tb00561.x | 1993 | |
| Eating Fermented: Health Benefits of LAB-Fermented Foods. | Castellone V, Bancalari E, Rubert J, Gatti M, Neviani E, Bottari B. | Foods | 10.3390/foods10112639 | 2021 | ||
| Assessment of the microbiota in microdissected tissues of Crohn's disease patients. | De Hertogh G, Lemmens B, Verhasselt P, de Hoogt R, Sagaert X, Joossens M, Van Assche G, Rutgeerts P, Vermeire S, Aerssens J. | Int J Inflam | 10.1155/2012/505674 | 2012 | ||
| Pathogenicity | Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. | Samuelson DR, Shellito JE, Maffei VJ, Tague ED, Campagna SR, Blanchard EE, Luo M, Taylor CM, Ronis MJJ, Molina PE, Welsh DA. | PLoS Pathog | 10.1371/journal.ppat.1006426 | 2017 | |
| Enzymology | Biliary Microbiota, Gallstone Disease and Infection with Opisthorchis felineus. | Saltykova IV, Petrov VA, Logacheva MD, Ivanova PG, Merzlikin NV, Sazonov AE, Ogorodova LM, Brindley PJ. | PLoS Negl Trop Dis | 10.1371/journal.pntd.0004809 | 2016 | |
| Enzymology | Succinivibrionaceae is dominant family in fecal microbiota of Behçet's Syndrome patients with uveitis. | Tecer D, Gogus F, Kalkanci A, Erdogan M, Hasanreisoglu M, Ergin C, Karakan T, Kozan R, Coban S, Diker KS. | PLoS One | 10.1371/journal.pone.0241691 | 2020 | |
| A Multi-omics Approach to Unraveling the Microbiome-Mediated Effects of Arabinoxylan Oligosaccharides in Overweight Humans. | Benitez-Paez A, Kjolbaek L, Gomez Del Pulgar EM, Brahe LK, Astrup A, Matysik S, Schott HF, Krautbauer S, Liebisch G, Boberska J, Claus S, Rampelli S, Brigidi P, Larsen LH, Sanz Y. | mSystems | 10.1128/msystems.00209-19 | 2019 | ||
| Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota. | Martin R, Makino H, Cetinyurek Yavuz A, Ben-Amor K, Roelofs M, Ishikawa E, Kubota H, Swinkels S, Sakai T, Oishi K, Kushiro A, Knol J. | PLoS One | 10.1371/journal.pone.0158498 | 2016 | ||
| Genetics | Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach. | Wei X, Yan X, Zou D, Yang Z, Wang X, Liu W, Wang S, Li X, Han J, Huang L, Yuan J. | BMC Gastroenterol | 10.1186/1471-230x-13-175 | 2013 | |
| Metabolism | Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition. | Drabavicius G, Drabavicius G, Daelemans D. | PLoS Genet | 10.1371/journal.pgen.1009387 | 2021 | |
| Metabolism | Heparan sulfate is essential for thymus growth. | Hsu HP, Chen YT, Chen YY, Lin CY, Chen PY, Liao SY, Lim CCY, Yamaguchi Y, Hsu CL, Dzhagalov IL. | J Biol Chem | 10.1016/j.jbc.2021.100419 | 2021 | |
| Role of the gut microbiome in three major psychiatric disorders. | Borkent J, Ioannou M, Laman JD, Haarman BCM, Sommer IEC, Sommer IEC. | Psychol Med | 10.1017/s0033291722000897 | 2022 | ||
| Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder. | Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, Veenstra-VanderWeele J, Anderson GM, Savidge T, Williams KC. | Cell Mol Gastroenterol Hepatol | 10.1016/j.jcmgh.2016.11.008 | 2017 | ||
| Metabolism | A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. | Sharma AK, Jaiswal SK, Chaudhary N, Sharma VK. | Sci Rep | 10.1038/s41598-017-10203-6 | 2017 | |
| Enzymology | Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet. | Roager HM, Licht TR, Poulsen SK, Larsen TM, Bahl MI. | Appl Environ Microbiol | 10.1128/aem.03549-13 | 2014 | |
| Metabolism | Administration of Inulin-Supplemented Gluten-Free Diet Modified Calcium Absorption and Caecal Microbiota in Rats in a Calcium-Dependent Manner. | Krupa-Kozak U, Markiewicz LH, Lamparski G, Juskiewicz J. | Nutrients | 10.3390/nu9070702 | 2017 | |
| Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility. | Dinakaran V, Mandape SN, Shuba K, Pratap S, Sakhare SS, Tabatabai MA, Smoot DT, Farmer-Dixon CM, Kesavalu LN, Adunyah SE, Southerland JH, Gangula PR. | Front Microbiol | 10.3389/fmicb.2018.03220 | 2018 | ||
| Phylogeny | Host contributes to longitudinal diversity of fecal microbiota in swine selected for lean growth. | Lu D, Tiezzi F, Schillebeeckx C, McNulty NP, Schwab C, Shull C, Maltecca C. | Microbiome | 10.1186/s40168-017-0384-1 | 2018 | |
| Pathogenicity | Salmonella enterica Serovar Typhimurium Temporally Modulates the Enteric Microbiota and Host Responses To Overcome Colonization Resistance in Swine. | Bescucci DM, Moote PE, Ortega Polo R, Uwiera RRE, Inglis GD. | Appl Environ Microbiol | 10.1128/aem.01569-20 | 2020 | |
| Pathogenicity | Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition. | Paul B, Royston KJ, Li Y, Stoll ML, Skibola CF, Wilson LS, Barnes S, Morrow CD, Tollefsbol TO. | PLoS One | 10.1371/journal.pone.0189756 | 2017 | |
| Genetics | The impact of sequence database choice on metaproteomic results in gut microbiota studies. | Tanca A, Palomba A, Fraumene C, Pagnozzi D, Manghina V, Deligios M, Muth T, Rapp E, Martens L, Addis MF, Uzzau S. | Microbiome | 10.1186/s40168-016-0196-8 | 2016 | |
| Genetics | In vitro culture conditions for maintaining a complex population of human gastrointestinal tract microbiota. | Kim BS, Kim JN, Cerniglia CE. | J Biomed Biotechnol | 10.1155/2011/838040 | 2011 | |
| Structural and functional characterization of shaft, anchor, and tip proteins of the Mfa1 fimbria from the periodontal pathogen Porphyromonas gingivalis. | Hall M, Hasegawa Y, Yoshimura F, Persson K. | Sci Rep | 10.1038/s41598-018-20067-z | 2018 | ||
| Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. | Ramanan D, Tang MS, Bowcutt R, Loke P, Cadwell K. | Immunity | 10.1016/j.immuni.2014.06.015 | 2014 | ||
| Enzymology | Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. | Bergstrom A, Skov TH, Bahl MI, Roager HM, Christensen LB, Ejlerskov KT, Molgaard C, Michaelsen KF, Licht TR. | Appl Environ Microbiol | 10.1128/aem.00342-14 | 2014 | |
| Pathogenicity | Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility. | Almeida FS, Nakano V, Avila-Campos MJ. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2007.00732.x | 2007 | |
| Metabolism | The Stringent Response Determines the Ability of a Commensal Bacterium to Survive Starvation and to Persist in the Gut. | Schofield WB, Zimmermann-Kogadeeva M, Zimmermann M, Barry NA, Goodman AL. | Cell Host Microbe | 10.1016/j.chom.2018.06.002 | 2018 | |
| Phylogeny | Real-time analysis of gut flora in Entamoeba histolytica infected patients of Northern India. | Verma AK, Verma R, Ahuja V, Paul J. | BMC Microbiol | 10.1186/1471-2180-12-183 | 2012 | |
| Pathogenic potential of Campylobacter ureolyticus. | Burgos-Portugal JA, Kaakoush NO, Raftery MJ, Mitchell HM. | Infect Immun | 10.1128/iai.06031-11 | 2012 | ||
| Metabolism | Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism. | Khalaj AJ, Sterky FH, Sclip A, Schwenk J, Brunger AT, Fakler B, Sudhof TC. | J Cell Biol | 10.1083/jcb.202004164 | 2020 | |
| Genetics | Comparative Genomic Analysis of the Human Gut Microbiome Reveals a Broad Distribution of Metabolic Pathways for the Degradation of Host-Synthetized Mucin Glycans and Utilization of Mucin-Derived Monosaccharides. | Ravcheev DA, Thiele I. | Front Genet | 10.3389/fgene.2017.00111 | 2017 | |
| Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut. | Zitomersky NL, Coyne MJ, Comstock LE. | Infect Immun | 10.1128/iai.01348-10 | 2011 | ||
| Metabolism | The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. | Erridge C, Duncan SH, Bereswill S, Heimesaat MM. | PLoS One | 10.1371/journal.pone.0009125 | 2010 | |
| Metabolism | Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase. | Ulmer JE, Vilen EM, Namburi RB, Benjdia A, Beneteau J, Malleron A, Bonnaffe D, Driguez PA, Descroix K, Lassalle G, Le Narvor C, Sandstrom C, Spillmann D, Berteau O. | J Biol Chem | 10.1074/jbc.m114.573303 | 2014 | |
| Phylogeny | PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes. | Stubbs SL, Brazier JS, Talbot PR, Duerden BI. | J Clin Microbiol | 10.1128/jcm.38.9.3209-3213.2000 | 2000 | |
| Phylogeny | New degenerate Cytophaga-Flexibacter-Bacteroides-specific 16S ribosomal DNA-targeted oligonucleotide probes reveal high bacterial diversity in River Taff epilithon. | O'Sullivan LA, Weightman AJ, Fry JC. | Appl Environ Microbiol | 10.1128/aem.68.1.201-210.2002 | 2002 | |
| Enzymology | Quantitative multiplexing analysis of PCR-amplified ribosomal RNA genes by hierarchical oligonucleotide primer extension reaction. | Wu JH, Liu WT. | Nucleic Acids Res | 10.1093/nar/gkm413 | 2007 | |
| Ecological characterization of the colonic microbiota of normal and diarrheic dogs. | Bell JA, Kopper JJ, Turnbull JA, Barbu NI, Murphy AJ, Mansfield LS. | Interdiscip Perspect Infect Dis | 10.1155/2008/149694 | 2008 | ||
| Pathogenicity | Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. | Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. | Antimicrob Agents Chemother | 10.1128/aac.45.4.1238-1243.2001 | 2001 | |
| Enzymology | Use of randomly cloned DNA fragments for identification of Bacteroides thetaiotaomicron. | Salyers AA, Lynn SP, Gardner JF. | J Bacteriol | 10.1128/jb.154.1.287-293.1983 | 1983 | |
| Phylogeny | Genome-Based Taxonomic Classification of Bacteroidetes. | Hahnke RL, Meier-Kolthoff JP, Garcia-Lopez M, Mukherjee S, Huntemann M, Ivanova NN, Woyke T, Kyrpides NC, Klenk HP, Goker M. | Front Microbiol | 10.3389/fmicb.2016.02003 | 2016 | |
| Phylogeny | Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. | Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J. | Appl Environ Microbiol | 10.1128/aem.65.11.4799-4807.1999 | 1999 | |
| Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. | Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. | Appl Environ Microbiol | 10.1128/aem.67.2.561-568.2001 | 2001 | ||
| Enzymology | Cloning, expression, and characterization of a novel heparinase I from Bacteroides eggerthii. | Liu CY, Su WB, Guo LB, Zhang YW | Prep Biochem Biotechnol | 10.1080/10826068.2019.1709977 | 2020 | |
| Phylogeny | Paraphocaeicola brunensis gen. nov., sp. nov., Carrying Two Variants of nimB Resistance Gene from Bacteroides fragilis, and Caecibacteroides pullorum gen. nov., sp. nov., Two Novel Genera Isolated from Chicken Caeca. | Kralova S, Davidova-Gerzova L, Valcek A, Bezdicek M, Rychlik I, Rezacova V, Cizek A. | Microbiol Spectr | 10.1128/spectrum.01954-21 | 2022 | |
| Phylogeny | Bacteroides barnesiae sp. nov., Bacteroides salanitronis sp. nov. and Bacteroides gallinarum sp. nov., isolated from chicken caecum. | Lan PTN, Sakamoto M, Sakata S, Benno Y | Int J Syst Evol Microbiol | 10.1099/ijs.0.64517-0 | 2006 |
| #9017 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 20697 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 ) |
| #41096 | ; Curators of the CIP; |
| #45195 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 9559 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68380 | Automatically annotated from API rID32A . |
| #68381 | Automatically annotated from API rID32STR . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #118999 | Collection of Institut Pasteur ; Curators of the CIP; CIP 104285 |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive1583.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data